false
--12-31
0001463972
0001463972
2024-09-03
2024-09-03
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported)
September 3, 2024
VUZIX CORPORATION
(Exact name of registrant as specified in
its charter)
Delaware
(State or Other Jurisdiction of Incorporation)
001-35955 |
04-3392453 |
(Commission File Number) |
(IRS Employer Identification No.) |
25 Hendrix Road, Suite A
West
Henrietta, New York 14586
(Address of principal executive offices)(Zipcode)
(585) 359-5900
(Registrant’s Telephone Number, Including
Area Code)
Not Applicable
(Former Name or Former Address, if Changed
Since Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered or to be registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock, par value $0.001 |
|
VUZI |
|
Nasdaq Capital Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate
by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 1.01 Entry into a Material Definitive
Agreement.
On September 3, 2024, Vuzix Corporation (the “Company”)
entered into a securities purchase agreement (the “Purchase Agreement”) with Quanta Computer Inc. (“Quanta”),
for the sale by the Company to Quanta of (i) $10,000,000 of the Company’s common stock, and up to (ii) $10,000,000 of the Company’s
newly created Series B Preferred Stock.
The first closing under the Purchase Agreement,
for the sale of $10,000,000 of the Company’s common stock at a purchase price of $1.30 per share, will occur fifteen business days
after the day on which closing conditions for such closing are met or waived, or such other date as may be agreed to between the Company
and Quanta.
The second closing under the Purchase Agreement,
for the sale of $5,000,000 of the Company’s Series B Preferred Stock, at a purchase price per share equal to the higher of (a) $13.00
or (b) ten times the volume-weighted average sale price of the common stock for the thirty trading days before the date on which the conditions
for the second closing are met, will occur fifteen business days after the day on which closing conditions for such closing are met or
waived, or such other date as may be agreed to between the Company and Quanta. The second closing will be subject to, among other closing
conditions, the Waveguide Plate Production Capacity Rate (as defined under the Purchase Agreement) at the Company’s Rochester waveguide
manufacturing plant being reasonably demonstrated to reach certain production levels and yields based on a Sampled run-rate basis (as
defined in the Purchase Agreement).
The third closing under the Purchase Agreement,
for the sale of $5,000,000 of the Company’s Series B Preferred Stock, at a purchase price per share equal to the higher of (a) $13.00
or (b) ten times the volume-weighted average sale price of the common stock for the thirty trading days before the date on which the conditions
for the third closing are met, will occur fifteen business days after the day on which closing conditions for such closing are met or
waived, or such other date as may be agreed to between the Company and Quanta. The third closing will be subject to, among other closing
conditions, the Waveguide Plate Production Capacity Rate at the Company’s Rochester waveguide manufacturing plant being reasonably
demonstrated to reach certain production levels and yields based on a Sampled run-rate basis.
The Purchase Agreement may be terminated by either
party if the second closing has not occurred within 12 months from the date of the Purchase Agreement, or if the third closing has not
occurred within 18 months from the date of the Purchase Agreement.
In connection with the Purchase Agreement, on
September 3, 2024, the Company and Quanta entered into a registration rights agreement (the “Registration Rights Agreement”).
Pursuant to the Registration Rights Agreement, the Company agreed to use commercially reasonable efforts to file a registration statement
with the Securities and Exchange Commission (the “SEC”) for the resale of the shares of common stock and shares underlying
the Series B Preferred Stock, issuable under the Purchase Agreement, within 45 days of the first closing under the Purchase Agreement,
and to have such registration statement declared effective within 60 days of the first closing (or 90 days if the registration statement
is reviewed by the SEC).
In connection with the foregoing, the Company
relied upon the exemption from registration provided by Section 4(a)(2) under the Securities Act of 1933, as amended, for transactions
not involving a public offering.
The above description of the material terms of
the Purchase Agreement and the Registration Rights Agreement are qualified in their entirety by reference to the text of such agreements
which are filed as exhibits to this report.
Item 3.02 Unregistered Sales of Equity Securities.
The
information set forth in Item 1.01 is incorporated by reference herein.
Item 5.03 Amendments to Articles of Incorporation
or Bylaws; Change in Fiscal Year
In connection with the Purchase Agreement, on
September 3, 2024, the Company filed a certificate of designation of Series B Preferred Stock with the Secretary of State of Delaware.
Pursuant to the certificate of designation, the Company designated 800,000 shares as Series B Preferred Stock. The Series B Preferred
Stock will entitle the holders to cumulative dividends at the annual rate of 1.5% of the original issuance price, payable quarterly. Upon
any liquidation of the Company, holders of Series B Preferred Stock will be entitled to receive the original issuance price, plus any
accrued dividends, prior to any payments to holders of common stock. Each share of Series B Preferred Stock will be convertible, at the
option of the holder, into ten shares of common stock, subject to adjustment for stock splits, stock dividends, and similar transactions.
If a Triggering Event (as defined in the certificate of designation) occurs, holders may, at their option, require the Company to redeem
the Series B Preferred Stock at a redemption price equal to the original issuance price plus any accrued dividends. The Company may, at
its option at any time, redeem the Series B Preferred Stock. The Series B Preferred Stock will not entitle the holders to voting rights,
except with respect to certain actions which will require the consent of the holders of 66 2/3% of the outstanding shares of Series B
Preferred Stock, or as required by law.
The foregoing summary of the certificate of designation
is subject to the full text of the certificate of designation, which is filed as an exhibit to this report.
Item 8.01 Other Events.
On September 3, 2024, the Company issued a press
release regarding the Purchase Agreement. A copy of the press release is filed as Exhibit 99.1 to this report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
* Portions of this agreement have been omitted.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: September 3, 2024 |
VUZIX CORPORATION |
|
|
|
| By: |
/s/ Grant Russell |
|
|
Grant Russell
Chief Financial Officer |
Exhibit 3.1
CERTIFICATE OF DESIGNATION, PREFERENCES AND RIGHTS
OF
SERIES B PREFERRED STOCK OF
VUZIX CORPORATION
Vuzix Corporation (the “Corporation”),
a corporation organized and existing under the laws of Delaware, does hereby certify that, pursuant to authority conferred upon the Board
of Directors of the Corporation by the Certificate of Incorporation of the Corporation, it has adopted resolutions (a) authorizing the
creation of Series B Preferred Stock of the Corporation and (b) providing for the designations, preferences and relative participating,
optional or other rights, and the qualifications, limitations or restrictions thereof, as follows:
SECTION 1.
Designation of Series. The shares of such series shall be designated as the “Series B Preferred Stock” and the
number of authorized shares initially constituting such series shall be eight hundred thousand (800,000) shares.
SECTION 2.
Ranking. The Series B Preferred Stock will rank, with respect to dividend rights and rights upon Liquidation Events:
| (a) | senior to the Common Stock, Series A Preferred Stock and each other class or series of Capital Stock (including
without limitation, any other series of preferred stock) of the Corporation now existing or hereafter authorized, classified or reclassified,
contingent equity liabilities and future equity distributions of the Corporation which do not expressly provide that such class or series
ranks on a parity basis with the Series B Preferred Stock as to dividend rights and rights on the distribution of assets on any voluntary
or involuntary liquidation, dissolution or winding up of the affairs of the Corporation (such Capital Stock, “Junior Stock”);
and |
| (b) | on a parity basis with each other class or series of Capital Stock of the Corporation hereafter authorized,
classified or reclassified, the terms of which expressly provide that such class or series ranks on a parity basis with the Series B Preferred
Stock as to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation, dissolution or winding
up of the affairs of the Corporation (such Capital Stock, “Parity Stock”). |
SECTION 3.
Definitions. As used herein with respect to Series B Preferred Stock:
“Accrued Dividends”
means, as of any date, with respect to any shares of Series B Preferred Stock, all dividends that have accrued on such shares pursuant
to Section 4, whether or not declared, but that have not, as of such date, been paid in cash.
“Affiliate”
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls, is controlled
by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act.
“Board” means
the Board of Directors of the Corporation or any committee thereof duly authorized to act on behalf of such Board of Directors for the
purposes in question.
“Business Day”
means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Taiwan are authorized or required
by law to remain closed.
“By-Laws” means
the Amended and Restated By-Laws of the Corporation, as may be amended from time to time.
“Capital Stock”
means, with respect to any Person, any and all shares of, interests in, rights to purchase, warrants to purchase, options for, participations
in or other equivalents of or interests in (however designated) stock issued by such Person.
“Certificate of Designations”
means this Certificate of Designation, Preferences and Rights, as may be amended from time to time.
“Certificate of Incorporation”
means the Certificate of Incorporation of the Corporation, as may be amended from time to time.
“close of business”
means 5:00 p.m. (New York City time).
“Common Stock”
means the common stock, par value $0.001 per share, of the Corporation.
“Company” has
the meaning set forth in the recitals above.
“Conversion
Obligation” means the amount and kind of consideration due upon a conversion of the Series B Preferred Stock in accordance
with the terms of Section 8.
“Conversion Shares”
means the shares of Common Stock then issuable upon a conversion of the Series B Preferred Stock in accordance with the terms of Section
8.
“Dividend Payment Date”
means each January 1, April 1, July 1 and October 1 of each year, beginning on the first such date after the first Original Issuance Date.
“Dividend Period”
means the period from, and including, a Dividend Payment Date to, but excluding, the next Dividend Payment Date, except that the initial
Dividend Period shall commence on, and include, the Original Issuance Date and shall end on, but exclude, the first Dividend Payment Date.
“Exchange Act”
means the Securities Exchange Act of 1934, as amended.
“Holder” means
a Person in whose name any Series B Preferred Stock is registered in the Register.
“Internal Revenue Code”
means the Internal Revenue Code of 1986, as amended.
“Junior Stock”
has the meaning set forth in Section 2(a).
“Liquidation Event”
means any voluntary or involuntary liquidation, dissolution or winding up of the affairs of the Corporation.
“Liquidation Preference”
means, with respect to any share of Series B Preferred Stock, as of any date, the Original Issuance Price increased by Accrued Dividends
with respect to such share.
“NASDAQ” means
The Nasdaq Capital Market (or its successor).
“Notice of Redemption”
has the meaning set forth in Section 6(e)(i).
“Original Issuance Date”
means, with respect to a share of Series B Preferred Stock, the dates of on which such share is issued pursuant to the Securities Purchase
Agreement.
“Original Issuance Price”
means, as of the Original Issuance Date, for each share of Series B Preferred Stock, a dollar amount equal to the applicable Per Share
Purchase Price (as such term defined in the Securities Purchase Agreement).
“Person” means
any individual, corporation, estate, partnership, joint venture, association, joint-stock company, limited liability company, trust, unincorporated
organization or any other entity.
“Preferred Stock”
means the preferred stock, par value $0.001, of the Corporation.
“Record Holder”
means, with respect to any Dividend Payment Date, a Holder of record of the Series B Preferred Stock as such Holder appears on the stock
register of the Corporation at the close of business on the related Regular Record Date.
“Redemption Date”
means a date that is fixed for redemption of the Series B Preferred Stock by the Corporation in accordance with Section 6.
“Redemption Price”
means the Optional Redemption Price and the Protective Redemption Price, as applicable.
“Register”
means the securities register maintained in respect of the Preferred Stock by the Corporation.
“Regular Record Date”
means, with respect to any Dividend Payment Date, the fifteenth day of each month preceding the month of each Dividend Payment Date, immediately
preceding the applicable Dividend Payment Date, respectively. The Regular Record Dates shall apply regardless of whether a particular
Regular Record Date is a Business Day.
“Securities Purchase
Agreement” means that certain Securities Purchase Agreement between the Corporation and Quanta Computer Inc., dated as of September
3, 2024, as it may be amended, supplemented or otherwise modified from time to time, with respect to the issuance and sale of certain
shares of Common Stock and Preferred Stock.
“Series A Preferred Stock”
means the series A preferred stock, par value $0.001 per share, of the Corporation.
“Series B Preferred Stock”
has the meaning set forth in Section 1.
“Subsidiary”
means any Person in which the Corporation, directly or indirectly, (I) owns any of the outstanding capital stock or holds any equity or
similar interest of such Person or (II) controls or operates all or any part of the business, operations or administration of such Person,
and each of the foregoing, is individually referred to herein as a “Subsidiary.”
“Super Majority Holders”
means Holders representing at least sixty-six and two-thirds percent (66 2/3%) of the then-issued and outstanding shares of Series B Preferred
Stock.
“Tax” or “Taxes”
means all present or future taxes, levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees
or other charges imposed by any governmental authority, including any interest, additions to tax or penalties applicable thereto.
“Trading Day”
means a day on which the NASDAQ is open for business.
“Transfer Agent”
means the Person acting as Transfer Agent, Registrar and paying agent for the Common Stock and its successors and assigns, which may be
the Corporation or one of its Affiliates.
“Trigger Event”
means:
| (a) | failure by the Corporation to make any payment of dividends on any Dividend Payment Date or any other
amounts (including, without limitation, the Liquidation Amount, the redemption prices pursuant to Section 6) as required
hereunder when the same becomes due and payable, and such failure continues for thirty (30) continuous days; |
| (b) | the Corporation or any of its Subsidiaries materially fail to comply with any of the covenants hereunder,
including failure of the Corporation to comply with its obligation to convert the Series B Preferred Stock in accordance
with this Certificate of Designations upon exercise of a Holder’s conversion right, and such failure continues for thirty (30) continuous
days; |
| (c) | the Corporation contests in writing the validity or enforceability of this Certificate of Designations
or any provision herein and fails to withdraw such contestation within ten (10) days thereafter; |
| (d) | any change in or amendment to the laws, regulations and rules of the United
States or the official interpretation or official application thereof, as a result of which a Holder’s continuance
holding of the shares of Series B Preferred Stock is prohibited; or |
| (e) | the Corporation commences or is subject to a case or proceeding pursuant
to or within the meaning of any bankruptcy or insolvency law. |
SECTION 4.
Dividends.
| (a) | Rate. Holders shall be entitled to receive, and the Corporation shall pay, cumulative dividends
at the rate per annum of 1.5% on the Original Issuance Price per share of Series B Preferred Stock (the “Dividend Amount”),
payable in cash. No dividends upon shares of the Series B Preferred Stock shall be authorized by the Board or declared by the Corporation
or paid or set apart by the Corporation at such times as such authorization, declaration, payment or setting apart for payment shall be
restricted or prohibited by law. Declared dividends on the Series B Preferred Stock shall be payable quarterly on each Dividend Payment
Date at such annual rate, and dividends shall accumulate from the most recent date as to which dividends shall have been paid or, if no
dividends have been paid, from the Original Issuance Date, whether or not in any Dividend Period or Dividend Periods there have been funds
legally available for the payment of such dividends. Declared dividends shall be payable on the relevant Dividend Payment Date to Record
Holders at the close of business on the immediately preceding Regular Record Date, whether or not the shares of Series B Preferred Stock
held by such Record Holders on such Regular Record Date are converted, redeemed or repurchased after such Regular Record Date. If a Dividend
Payment Date is not a Business Day, payment shall be made on the next succeeding Business Day, without any interest or other payment in
lieu of interest accruing with respect to this delay. |
The amount of dividends
payable on each share of Series B Preferred Stock for each full Dividend Period (after the initial Dividend Period) shall be computed
by dividing the Dividend Amount by four. Dividends payable on the Series B Preferred Stock for the initial Dividend Period and any partial
Dividend Period shall be computed based upon the number of days elapsed during such period over a 360-day year (consisting of twelve 30-day
months). Accumulated dividends shall accrue interest per annum at the rate at which dividends accumulate on the Series B Preferred Stock
if they are paid subsequent to the applicable Dividend Payment Date, from, and including, such Dividend Payment Date to, but excluding,
the date on which such dividends shall have been paid by the Corporation, payable in cash out of funds legally available for the payment
of such amounts.
Dividends on any share
of Series B Preferred Stock converted to Common Stock shall cease to accumulate on the Conversion Date.
| (b) | Priority of Dividends. So long as any share of the Series B Preferred Stock remains outstanding,
no cash dividend or equivalent distribution shall be declared or paid on Common Stock or any other shares of Junior Stock, and no Common
Stock or other Junior Stock shall be, directly or indirectly, purchased, redeemed or otherwise acquired for consideration by the Corporation
or any of its Subsidiaries unless all accumulated and unpaid dividends for all preceding Dividend Periods have been declared and paid
upon, or a sufficient sum of cash has been set apart for the payment of such dividends upon, all outstanding shares of Series B Preferred
Stock. |
When dividends on shares
of Series B Preferred Stock have not been paid in full on any Dividend Payment Date or declared and a sum sufficient for payment thereof
has not been set aside for the benefit of the Record Holders thereof on the applicable Regular Record Date, no dividends may be declared
or paid on any Parity Stock (other than dividends or distributions in the form of Parity Stock and Junior Stock and cash solely in lieu
of fractional shares in connection with such dividend or distribution) unless dividends are declared on the Series B Preferred Stock such
that the respective amounts of such dividends declared on the Series B Preferred Stock and each such other class or series of Parity Stock
shall bear the same ratio to each other as all accumulated and unpaid dividends per share on the shares of the Series B Preferred Stock
and such class or series of Parity Stock (subject to their having been declared by the Board out of legally available funds) bear to each
other, in proportion to their respective liquidation preferences; provided that any unpaid dividends will continue to accumulate.
| (c) | Method of Payment of Dividends. Any declared dividend on the Series B Preferred Stock, whether
or not for a current Dividend Period or any prior Dividend Period, shall be paid by the Corporation in cash. |
SECTION 5.
Liquidation Rights.
| (a) | Liquidation. In the event of any Liquidation Event, the Holders shall
be entitled, out of assets legally available therefor, before any distribution or payment out of the assets of the Corporation may be
made to or set aside for the holders of any Junior Stock, and subject to the rights of the Corporation's existing and future creditors,
to receive in full a liquidating distribution in cash and in the amount per share of Series B Preferred Stock equal to the greater of
(x) the Liquidation Preference and (y) the amount the Holder would have received had such Holder, immediately prior to such Liquidation
Event, converted such share of Series B Preferred Stock into Common Stock (such greater amount, the “Liquidation Amount”). |
| (b) | Partial Payment. If in connection with any distribution
described in Section 5(a) above, the assets of the Corporation or proceeds therefrom are not sufficient to pay in full
the aggregate liquidating distributions required to be paid pursuant to Section 5(a) above to all Holders, the amounts
distributed to the Holders shall be paid pro rata in accordance with the respective aggregate liquidating distributions to which
they would otherwise be entitled if all amounts payable thereon were paid in full. |
SECTION 6.
Redemption.
| (a) | Optional Redemption. Shares of Series B Preferred Stock may be redeemed
by the Corporation in accordance with this Section 6(a). At any time or from time to time on or after the Original Issuance
Date, the Corporation, at its option, may redeem for cash any shares of Series B Preferred Stock at the redemption price per share of
Series B Preferred Stock equal to 100% multiplied by the Liquidation Preference (the “Optional Redemption Price”),
subject to Holders’ Conversion Rights. |
| (c) | Class Protective Provisions. Upon the occurrence of a Trigger Event,
each Holder may, at such Holder’s election, require the Corporation to redeem for cash (the “Trigger Event Redemption”)
all, but not less than all, of such Holder’s outstanding shares of Series B Preferred Stock at a purchase price per share of Series
B Preferred Stock equal to 100.00% multiplied by the Liquidation Preference (the “Protective Redemption Price”); provided,
however, the Corporation shall only be required to pay the Protective Redemption Price to the extent such purchase can be made
out of funds legally available therefor. |
| (d) | Redemption Date. If the Redemption Date falls after a Regular Record
Date for the payment of dividends declared on the Series B Preferred Stock before the Dividend Payment Date corresponding to that Regular
Record Date, Holders at the close of business on that Regular Record Date shall be entitled to receive the dividend payable on those shares
on the corresponding Dividend Payment Date. The price payable on such Redemption Date will include only the Redemption Price, but will
not include any amount in respect of dividends on the Series B Preferred Stock declared and payable on such corresponding Dividend Payment
Date. The Corporation shall pay in full the Redemption Price on the applicable Redemption Date. |
| (e) | Notice of Redemption; Notice of Trigger Event. |
| (i) | Notice of redemption of the Series B Preferred Stock pursuant to Section
6(a) (the “Notice of Redemption”) shall be given by facsimile, email, overnight courier or first class mail,
postage prepaid, addressed to the Holders of record of the Series B Preferred Stock. Such Notice of Redemption shall be delivered to each
Holder at least thirty (30) days and not more than sixty (60) days before the proposed redemption date and shall state:
(1) the applicable redemption date; (2) the number of shares of Series B Preferred Stock held by the Holder and to be redeemed; (3) the
applicable redemption price per share of Series B Preferred Stock; (4) the place or places where certificates for such shares of Series
B Preferred Stock, if any, are to be surrendered for payment. A Notice of Redemption shall be without prejudice to a Holder’s Conversion
Rights. |
| (ii) | Notice of the occurrence of a Trigger Event pursuant to Section 6(c) (the “Notice
of Trigger Event”) shall be given by facsimile, email, overnight courier or first class mail, postage prepaid, addressed to
the Holders of record of the Series B Preferred Stock. Such Notice of Trigger Event shall be mailed to each Holder as soon as practicable
after the occurrence of any Trigger Event but in any case not more than five (5) Business Days after the occurrence thereof. Such Notice
of Trigger Event shall state: (1) the date on which such Trigger Event occurred and the proposed redemption date; (2) the applicable redemption
price per share of Series B Preferred Stock; (3) that an election form is attached or where to obtain such an election form; and (4) the
date by which each such Holder shall be required to provide notice to the Corporation of its election to cause such redemption and the
place or places where such Holders must send their election form along with certificates for such shares of Series B Preferred Stock,
if any, are to be surrendered for payment. The date to be set by the Corporation by which each Holder shall be required to affirmatively
elect to cause the Corporation to so redeem its shares of Series B Preferred Stock shall be a date no earlier than fifteen (15) days after
the date such Notice of Trigger Event was delivered to all Holders, as aforesaid. If the Corporation fails to send the Notice of Trigger
Event in a timely fashion, Holders representing at least ten percent (10%) of the then-issued and outstanding shares of Series B Preferred
Stock may by notice in writing to the Corporation, request the Corporation to redeem all of its shares of Series B Preferred Stock. Such
notice shall describe the Trigger Event that has occurred and state the proposed redemption date. |
| (iii) | Each Holder electing to cause the Corporation to redeem its shares of Series
B Preferred Stock in accordance with Section 6(e)(ii) shall deliver its duly completed election form to the Corporation
by the date and at the location as set forth in the Notice of Trigger Event. Any such election may be withdrawn and cancelled by any such
Holder by further notice delivered to the Corporation no later than the Business Day prior to the specified date of redemption. |
| (f) | Treatment of Shares; Partial Redemption. Until a share of Series B
Preferred Stock is redeemed by the payment or deposit in full of the redemption price as provided in Section 6(g), such
share of Series B Preferred Stock will remain outstanding and will be entitled to all of the powers, designations, preferences and other
rights provided herein. In the event that an optional redemption is effected with respect to shares of Series B Preferred Stock representing
less than all shares of Series B Preferred Stock held by a Holder, promptly following such optional redemption, the Corporation shall
reflect in the Register the remaining shares of Series B Preferred Stock held by such Holder. |
| (g) | Sufficient Funds. If the Corporation shall not have sufficient funds
legally available to redeem all shares of Series B Preferred Stock required under this Section 6, the Corporation shall
(i) redeem, pro rata among the Holders, a number of shares of Series B Preferred Stock with an aggregate redemption price equal to the
amount legally available for the purchase of shares of Series B Preferred Stock and (ii) purchase any shares of Series B Preferred Stock
not purchased because of the foregoing limitations at the applicable redemption price as soon as practicable after the Corporation is
able to make such purchase out of assets legally available for the purchase of such share of Series B Preferred Stock. For the avoidance
of doubt, dividends will continue to accrue on the Preferred Stock until such time as the shares of Preferred Stock are actually purchased.
The inability of the Corporation (or its successor) to make a purchase payment for any reason shall not relieve the Corporation (or its
successor) from its obligation to effect any required purchase when, as and if permitted by applicable law. Notwithstanding the foregoing,
in the event a Holder exercises a Trigger Event Redemption pursuant to this Section 6 at a time when the Corporation is
restricted or prohibited (contractually or otherwise) from redeeming some or all of the Series B Preferred Stock subject to the Trigger
Event Redemption, the Corporation will use its reasonable best efforts to obtain the requisite consents to remove or obtain an exception
or waiver to such restrictions or prohibition. Nothing herein shall limit a Holder's right to pursue any other remedies available to it
hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect
to the Corporation's failure to comply with its obligations under this Section 6. For so long as a failure to comply with
this Section 6 has occurred and is continuing, the restrictions set forth in Section 4(b) with respect to
restrictions on dividends or distributions relating to Junior Stock shall apply mutatis mutandis. |
| (h) | With respect to any share of Series B Preferred Stock to be redeemed by the Corporation pursuant to Section
6(a) or Section 6(c) and which has been redeemed in accordance with the provisions of this Section
6, (i) such share shall no longer be deemed outstanding and (ii) all rights with respect to such share shall cease and terminate
other than the rights of the Holder thereof to receive the redemption price therefor. |
SECTION 7.
Voting Rights.
| (a) | General. No Holder shall be entitled to a vote on any matter submitted to a vote of stockholders of the
Corporation, except as otherwise provided herein or as required by applicable law. The Holders shall be entitled to notice of any stockholders’
meeting in accordance with the Certificate of Incorporation and the Bylaws as if they were holders of record of Common Stock for such
meeting. |
| (b) | Series B Preferred Stock Adverse Changes. So long as any shares of Series B Preferred Stock are
outstanding, in addition to any other vote required by applicable law, the Corporation may not take, and may not permit any of its Subsidiaries
to directly or indirectly take, any of the following actions (including by means of merger, consolidation, reorganization, recapitalization
or otherwise) without the prior affirmative vote or written consent from the Super Majority Holders, voting as a separate class: |
| (i) | amend, alter, repeal or otherwise modify any provision of the Certificate of Incorporation (including
this Certificate of Designations) in a manner that would adversely affect the powers, preferences, rights or privileges of the Series
B Preferred Stock; |
| (ii) | authorize, create, increase the authorized amount of, or issue any class or series of Capital Stock of
the Corporation or any security convertible into, or exchangeable or exercisable for any of the foregoing, or reclassify any security
into, any Capital Stock of the Corporation ranking senior to or pari passu with the Series B Preferred Stock with respect to dividend
rights and rights upon Liquidation Events; and |
| (iii) | increase or decrease the authorized number of shares of Series B Preferred Stock (except for the cancellation
and retirement of shares set forth in Section 10) or issue additional shares of Series B Preferred Stock other than in connection
with the transactions described in the Securities Purchase Agreement. |
| (c) | Each Holder of Series B Preferred Stock will have one (1) vote per share on any matter on which Holders
of Series B Preferred Stock are entitled to vote separately as a class, whether at a meeting or by written consent. |
| (d) | Until being issued upon the conversion of the Series B Preferred Stock, the shares of Common Stock issuable
upon conversion of the Series B Preferred Stock shall not be deemed to be outstanding and Holders shall have no voting rights with respect
to such shares of Common Stock by virtue of holding the Series B Preferred Stock. |
SECTION 8.
Conversion Rights. The Holders shall have conversion rights as follows (the “Conversion Rights”):
| (a) | Right to Convert. Each share of Series B Preferred Stock shall be convertible, at the option of
the respective Holder, from time to time following the Original Issuance Date of such share (including, for the avoidance of doubt, following
a Notice of Redemption is received but prior to the completion of redemption pursuant thereto), and without the payment of additional
consideration by the Holder, into such number of fully paid and non-assessable shares of Common Stock as is determined by dividing (i)
the Original Issuance Price increased by the Accrued Dividends by (ii) the applicable Conversion Price in effect as of the Conversion
Date (such result, the “Conversion Rate”). The “Conversion Price” for each share of Series B Preferred
Stock shall initially be (x) the Original Issuance Price of such share divided by (y) ten (10) and is subject to adjustment as provided
in this Section 8; and the initial Conversion Rate is ten (10). |
| (b) | Fractional Shares. The Corporation shall not issue any fractional shares of Common Stock upon conversion
of Series B Preferred Stock and in the event that any conversion of the shares of Series B Preferred Stock would result in the issuance
of a fractional share, the number of shares of Common Stock issued or issuable to such Holder shall be rounded up to the nearest whole
share of Common Stock. Whether or not there will be fractional shares upon such conversion shall be determined on the basis of the total
number of shares of Series B Preferred Stock the Holder is at the time converting into Common Stock and the aggregate number of shares
of Common Stock issuable to such Holder upon such conversion. |
| (c) | Procedures for Conversion; Effect of Conversion. |
| (i) | Procedures for Holder Conversion. Holders shall effect conversions by providing the Corporation
with a written notice of conversion (a “Notice of Conversion”) delivered in accordance with Section 13
on any Business Day. Each Notice of Conversion shall specify the number of shares of Series B Preferred Stock to be converted and the
date on which such conversion is to be effected, which date may not be prior to the date the applicable Holder delivers in writing (including
by facsimile or email) such Notice of Conversion to the Corporation (such date, the “Conversion Date”). If no Conversion
Date is specified in a Notice of Conversion, the Conversion Date shall be the date that such Notice of Conversion to the Corporation is
deemed delivered hereunder. To effect conversions of shares of Series B Preferred Stock in certificated form, a Holder shall not be required
to surrender the certificate(s) representing the shares of Series B Preferred Stock to the Corporation unless all of the shares of Series
B Preferred Stock represented thereby are so converted, in which case such Holder shall deliver the certificate representing such shares
of Series B Preferred Stock promptly following the Conversion Date at issue. |
The shares of Common
Stock shall be deemed to have been issued, and the Holder or any other Person so designated to be deemed to have become a holder of record
of such shares for all purposes, as of the close of business on the Conversion Date. Not later than 10:00 am (New York City time) on the
second Trading Day after each Conversion Date if shares are to be delivered in book-entry form or within five (5) Business Days otherwise
(the “Share Delivery Date”), the Corporation shall deliver, or cause to be delivered (through the facilities of DTC
and the Transfer Agent or in certificated form, as applicable), to the converting Holder the number of shares of Common Stock being acquired
upon the conversion of the Series B Preferred Stock. If, in the case of any Notice of Conversion, such shares of Common Stock are not
delivered to the applicable Holder or as directed by the applicable Holder by the Share Delivery Date, the Holder shall be entitled to
elect by written notice to the Corporation in accordance with Section 13 at any time on or before its receipt of such shares
of Common Stock, to rescind such conversion, in which event the Corporation shall promptly return to the Holder any original Series B
Convertible Stock certificate delivered to the Corporation.
In the event that
a conversion is effected pursuant to this Section 8 with respect to shares of Series B Preferred Stock representing less
than all the shares of Series B Preferred Stock held by a Holder, upon such conversion the Corporation shall execute and instruct the
Registrar (if applicable) to countersign and deliver to the Holder thereof, at the expense of the Corporation, a certificate evidencing
the shares of Series B Preferred Stock as to which conversion was not effected, or, if the Series B Preferred Stock is held in book-entry
form, the Corporation shall or shall cause the Registrar, if applicable, to reduce the number of shares of Series B Preferred Stock by
making a notation.
| (ii) | All shares of Series B Preferred Stock which shall have been surrendered for conversion as herein provided
shall no longer be deemed to be outstanding and all rights with respect to such shares, including the rights, shall immediately cease
and terminate at the time of conversion, except only the right of the Holders thereof to receive shares of Common Stock in exchange therefor. |
| (d) | Reservation of Stock. The Corporation shall, at all times when any shares of Series B Preferred
Stock are outstanding, reserve and keep available out of its authorized but unissued shares of Capital Stock, solely for the purpose of
issuance upon the conversion of the Series B Preferred Stock, for each share of then outstanding Series B Preferred Stock, the number
of shares of Common Stock issuable upon the conversion thereof pursuant to Section 8(a) based on the then applicable Conversion
Price (taking into account any adjustment to such number of shares so
issuable in accordance with Section 8(f) hereof). In the event that any such reservation of shares shall be determined by
the Corporation to be insufficient in light of the circumstances, the Corporation shall promptly adjust such reservation amount. In the
event that the Corporation would be required to reserve Common Stock in excess of its authorized Common Stock, the Corporation shall use
its best efforts to increase its number of authorized shares of Common Stock as necessary to satisfy its obligations under this Certificate
of Designations as promptly as reasonably practicable. The Corporation shall take all such actions as may be necessary to assure that
all such shares of Common Stock may be so issued without violation of any applicable law or governmental regulation and shall use commercially
reasonable efforts to take all such actions as may be necessary to assure that all such shares of Common Stock may be so issued without
violation of any requirements of any securities exchange upon which shares of Common Stock may be listed (except for official notice of
issuance which shall be immediately delivered by the Corporation upon each such issuance). The Corporation shall not close its books against
the transfer of any of its Capital Stock in any manner which would prevent the timely conversion of the shares of Series B Preferred Stock. |
| (e) | No Charge or Payment. The issuance of certificates for shares of Common Stock upon conversion of
shares of Series B Preferred Stock pursuant to this Certificate of Designations shall be made without payment of additional consideration
by, or other charge, cost or tax to, the Holder in respect thereof. The Corporation shall pay any and all issue and other similar taxes
that may be payable in respect of any issuance or delivery of shares of Common Stock upon conversion of shares of Series B Preferred Stock
pursuant to this Certificate of Designations. |
| (f) | Adjustment to Conversion Price and Number of Conversion Shares. The Conversion Price shall be adjusted
from time to time by the Corporation if any of the following events occur: |
| (i) | Adjustment for Share Splits and Combinations. If the Corporation
shall at any time, or from time to time after the Original Issuance Date, effect a subdivision of the outstanding Common Stock, the applicable
Conversion Price in effect immediately prior to such subdivision shall be proportionately decreased. Conversely, if the Corporation shall
at any time, or from time to time after the Original Issuance Date, combine the outstanding Common Stock into a smaller number of shares,
the applicable Conversion Price in effect immediately prior to the combination shall be proportionately increased. Any adjustment under
this paragraph shall become effective at the close of business on the date the subdivision or combination becomes effective. |
| (ii) | Adjustment for Common Stock Dividends and Distributions. If the Corporation
makes (or fixes a record date for the determination of holders of Common Stock entitled to receive) a dividend or other distribution solely
to the holders of Common Stock payable in Common Stock after the Original Issuance Date, the applicable Conversion Price then in effect
shall be decreased as of the time of such issuance (or in the event such record date is fixed, as of the close of business on such record
date) by multiplying the applicable Conversion Price then in effect by a fraction (i) the numerator of which is the total number of shares
of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and
(ii) the denominator of which is the total number of shares of Common Stock issued and outstanding immediately prior to the time of such
issuance or the close of business on such record date plus the number of Common Stock issuable in payment of such dividend or distribution. |
| (iii) | Adjustments for Other Dividends. If the Corporation at any
time, or from time to time after the Original Issuance Date, makes (or fixes a record date for the determination of holders of Common
Stock entitled to receive) a dividend or other distribution payable in securities of the Corporation other than Common Stock, then, and
in each such event, provision shall be made so that, upon conversion of any Series B Preferred Stock thereafter, the holder thereof shall
receive, in addition to the number of Common Stock issuable thereon, the amount of securities of the Corporation which the holder of such
Series B Preferred Stock would have received had the Series B Preferred Stock been converted into Common Stock immediately prior to such
event, all subject to further adjustment as provided herein. |
| (g) | Certificate as to Adjustment. |
| (i) | Promptly following any adjustment of the Conversion Price, the Corporation shall furnish to each Holder
at the address specified for such Holder in the books and records of the Corporation (or at such other address as may be provided to the
Corporation in writing by such Holder, which may be an electronic mail address) a certificate of an officer of the Corporation setting
forth in reasonable detail such adjustment and the facts upon which it is based and certifying the calculation thereof. |
| (ii) | As promptly as reasonably practicable following the receipt by the Corporation of a written request by
any Holder, but in any event not later than thirty (30) days thereafter, the Corporation shall furnish to such Holder a certificate of
an officer of the Corporation certifying the Conversion Price then in effect and the number of Conversion Shares or the amount, if any, of other
shares of stock, securities or assets then issuable to such Holder upon conversion of the shares of Series B Preferred Stock held by such
Holder. |
| (h) | Notices. In the event that the Corporation shall take a record of the holders of its Common Stock
(or other Capital Stock or securities at the time issuable upon conversion of the Series B Preferred Stock) for the purpose of entitling
or enabling them to receive any dividend or other distribution, to vote at a meeting (or by written consent), to receive any right to
subscribe for or purchase any shares of Capital Stock of any class or any other securities, or to receive any other security, then, unless
the Corporation has previously publicly announced such information (including through filing such information with the SEC), the Corporation
shall send or cause to be sent to each at the address specified for such Holder in the books and records of the Corporation (or at such
other address as may be provided to the Corporation in writing by such Holder, which may be an electronic mail address) at least ten (10)
calendar days prior to the applicable record date, the record date for such dividend, distribution, meeting or consent or other right
or action, and a description of such dividend, distribution or other right or action to be taken at such meeting or by written consent. |
SECTION 9.
Reorganization Events.
| (i) | any recapitalization, reclassification or change of the Common Stock (other than changes resulting from
a subdivision or combination), |
| (ii) | any consolidation, merger, combination or similar transaction involving the Corporation, |
| (iii) | any sale, lease or other transfer to a third party of the consolidated assets of the Corporation and the
Corporation’s Subsidiaries substantially as an entirety or |
| (iv) | any statutory share exchange, |
in each case, as a
result of which the Common Stock would be converted into, or exchanged for, stock, other securities, other property or assets
(including cash or any combination thereof) (any such event, a “Reorganization Event”), then, at and after the
effective time of such Reorganization Event, the right to convert each share of Series B Preferred Stock at the Conversion Rate
shall be changed into a right to convert such share into the kind and amount of shares of stock, other securities or other property
or assets (including cash or any combination thereof) that a holder of a number of shares of Common Stock equal to the Conversion
Rate immediately prior to such Reorganization Event would have owned or been entitled to receive (the “Reference
Property,” with each “unit of Reference Property” meaning the kind and amount of Reference Property that a holder
of one share of Common Stock is entitled to receive) upon such Reorganization Event; provided, however, that at and
after the effective time of the Reorganization Event (A) any amount payable in cash upon redemption, conversion, or repurchase of
the Series B Preferred Stock in accordance with the provisions hereof this Certificate of Designations shall continue to be payable
in cash as determined pursuant to the applicable provisions hereof, (B) any shares of Common Stock that the Corporation would have
been required to deliver upon redemption, conversion, or repurchase of the Series B Preferred Stock in accordance with the
applicable provisions hereof, shall instead be deliverable in the amount and type of Reference Property that a holder of that number
of shares of Common Stock would have been entitled to receive in such Reorganization Event.
| (b) | If the Reorganization Event causes the Common Stock to be converted into, or exchanged for, the right
to receive more than a single type of consideration (determined based in part upon any form of stockholder election), then (i) the Reference
Property into which the Series B Preferred Stock will be convertible or with which the Corporation may satisfy its obligation with respect
to any Redemption Price, shall be deemed to be (x) the weighted average of the types and amounts of consideration received by the holders
of Common Stock that affirmatively make such an election or (y) if no holders of Common Stock affirmatively make such an election, the
types and amounts of consideration actually received by the holders of Common Stock, and (ii) the unit of Reference Property for purposes
of the immediately preceding paragraph shall refer to the consideration referred to in clause (i) attributable to one share of Common
Stock. If the holders of the Common Stock receive only cash in such Reorganization Event, then for all conversions for which the relevant
Conversion Date occurs after the effective date of such Reorganization Event (A) the consideration due upon conversion of share of Series
B Preferred Stock shall be solely cash in an amount equal to the greater of (x) the Liquidation Preference per share and (y) the Conversion
Rate in effect on the Conversion Date, multiplied by the price paid per share of Common Stock in such Reorganization Event and
(B) the Corporation shall satisfy the Conversion Obligation by paying cash to converting Holders on the third Business Day immediately
following the relevant Conversion Date. The Corporation shall notify Holders of such weighted average as soon as practicable after such
determination is made. |
| (c) | The above provisions of this Section shall similarly apply to successive Reorganization Events and the
provisions of this Section shall apply to any Reference Property. |
| (d) | The Corporation (or any successor thereto) shall, as soon as reasonably practicable (but in any
event within 20 calendar days) after the occurrence of any Reorganization Event, provide written notice to the Holders of such occurrence and of the kind and amount
of the stock, other securities, other property or assets that constitute the Reference Property. Failure to deliver such notice shall
not affect the operation of this Section 9. |
| (e) | The Corporation shall not enter into or consummate any transaction or become a party to any agreement,
in each case, with respect to any transaction that would constitute a Reorganization Event unless its terms are consistent with the provisions
of Section 9(a). |
SECTION 10.
Status of Shares. Shares of Series B Preferred Stock that have been issued and reacquired in any manner, whether by redemption,
repurchase or otherwise, shall thereupon be retired and shall have the status of authorized and unissued shares of preferred stock of
the Corporation undesignated as to series, and may be redesignated as any series of preferred stock of the Corporation and reissued.
SECTION 11.
No Sinking Fund. Shares of Series B Preferred Stock shall not be subject to or entitled to the operation of a retirement
or sinking fund.
SECTION 12.
Taxes; Transfer Taxes. The Corporation shall pay any and all stock transfer, documentary, stamp and similar taxes that may
be payable in respect of any issuance or delivery of shares of Series B Preferred Stock or other securities issued on account of Series
B Preferred Stock pursuant hereto or certificates representing such shares or securities. The Corporation shall not, however, be required
to pay any such tax that may be payable in respect of any transfer involved in the issuance or delivery of shares of Series B Preferred
Stock or other securities in a name other than the name in which the shares of Series B Preferred Stock with respect to which such shares
or other securities are issued or delivered were registered, or in respect of any payment to any Person other than a payment to the registered
holder thereof, and shall not be required to make any such issuance, delivery or payment, unless and until the Person otherwise entitled
to such issuance, delivery or payment has paid to the Corporation the amount of any such tax or has established, to the satisfaction of
the Corporation, that such tax has been paid or is not payable. All payments and distributions (or deemed distributions) on the shares
of Series B Preferred Stock shall be subject to withholding and backup withholding of taxes to the extent required by law, subject to
applicable exemptions, and amounts withheld, if any, shall be treated as received by the Holders.
SECTION 13.
Notices. Any notices, consents, waivers or other communications required or permitted to be given must be in writing and
will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by facsimile (provided
confirmation of transmission is mechanically or electronically generated and kept on file by the sending party) or electronic mail (provided
that such sent email is kept on file (whether electronically or otherwise) by the sending party and the sending party does not receive
an automatically generated message from the recipient’s email server that such e-mail could not be delivered to such recipient);
or (iii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified, in each case, properly
addressed to the party to receive the same. The addresses, facsimile numbers and e-mail addresses for such communications shall be (a)
if to the Corporation, to its office at 25 Hendrix Road, West Henrietta, New York 14586, Telephone: 585-359-5900, Attention: General
Counsel, E-Mail: Legal@vuzix.com; (b) if to any Holder, at such address specified for such Holder in the books and records of
the Corporation (or at such other address as may be provided to the Corporation in writing by such Holder, which may be an electronic
mail address); or (c) to such other address as the Corporation or any such Holder, as the case may be, shall have designated by notice
similarly given.
SECTION 14.
Facts Ascertainable. When the terms of this Certificate of Designations refer to a specific agreement or other document
to determine the meaning or operation of a provision hereof, the Secretary of the Corporation shall maintain a copy of such agreement
or document at the principal executive offices of the Corporation and a copy thereof shall be provided free of charge to any Holder who
makes a request therefor. The Secretary of the Corporation shall also maintain a written record of the Original Issuance Date, the number
of shares of Series B Preferred Stock issued to a Holder and shall furnish such written record free of charge to any Holder who makes
a request therefor.
SECTION 15.
Waiver. Notwithstanding any provision in this Certificate of Designations to the contrary, any provision contained herein
and any right of the Holders of Series B Preferred Stock granted hereunder may be waived as to all shares of Series B Preferred Stock
(and the Holders thereof) upon the written consent of the Super Majority Holders.
SECTION 16.
Severability. If any term of the Series B Preferred Stock set forth herein is invalid, unlawful or incapable of being enforced
by reason of any rule of law or public policy, all other terms set forth herein, which can be given effect without the invalid, unlawful
or unenforceable term will, nevertheless, remain in full force and effect, and no term herein set forth will be deemed dependent upon
any other such term, unless so expressed herein.
SECTION 17.
No Preemptive Rights. The Holders shall have no preemptive or preferential rights to purchase or subscribe for any stock,
obligations, warrants or other securities of the Corporation of any class or series.
SECTION 18.
No Other Rights. The Series B Preferred Stock will have no rights, preferences, privileges or voting powers or relative,
participating, optional or other special rights, or qualifications, limitations or restrictions thereof, except as provided in this Certificate
of Designations or the Certificate of Incorporation or as provided by applicable law.
SECTION 19.
Stock Certificates.
| (a) | Shares of Series B Preferred Stock shall, if expressly requested by the Holder, initially be represented
by stock certificates, and shall otherwise be issued in book entry form. |
| (b) | Stock certificates representing shares of the Series B Preferred Stock shall be signed by officers of
the Company in accordance with the Bylaws and applicable Delaware law, by manual or facsimile signature. |
SECTION 20.
Replacement Certificates. If physical certificates are issued, and any of the Series B Preferred Stock certificates shall
be mutilated, lost, stolen or destroyed, the Corporation shall, at the expense of the Holder, issue, in exchange and in substitution for
and upon cancellation of the mutilated Series B Preferred Stock certificate, or in lieu of and substitution for the Series B Preferred
Stock certificate lost, stolen or destroyed, a new Series B Preferred Stock certificate of like tenor and representing an equivalent Liquidation
Preference of shares of Series B Preferred Stock, but only upon receipt of evidence of such loss, theft or destruction of such Series
B Preferred Stock certificate and indemnity, if requested, reasonably satisfactory to the Corporation.
SECTION 21.
Rule 144A. At any time the Corporation is not subject to the reporting requirements under Section 13 or 15(d) of the Exchange
Act, the Corporation shall, upon written request, furnish to any Holder, beneficial owner or prospective purchaser of the Series B Preferred
Stock, the information required to be delivered pursuant to Rule 144A(d)(4) under the Securities Act of 1933, as amended (the “Securities
Act”), to facilitate the resale of such Series B Preferred Stock pursuant to Rule 144A under the Securities Act. The Corporation
shall take such further action as any such beneficial owner may reasonably request to the extent required from time to time to enable
such beneficial Holder to sell such Series B Preferred Stock in accordance with Rule 144A under the Securities Act, as such rule may be
amended from time to time.
SECTION 22.
Miscellaneous. The Liquidation Preference and the Dividend Amount each shall be subject to equitable adjustment whenever
there shall occur a stock split, combination, reclassification or other similar event involving the Series B Preferred Stock. Such adjustments
shall be determined in good faith by the Corporation.
[Signature page follows.]
IN WITNESS WHEREOF the undersigned
has signed this Certificate of Designation this 3rd day of September, 2024.
Vuzix Corporation
By: |
/s/ Paul Travers |
|
Name: Paul
Travers |
|
Title: Chief
Executive Officer |
|
Exhibit 10.1
Certain
identified information has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive
harm to the registrant if publicly disclosed.
SECURITIES PURCHASE
AGREEMENT
This SECURITIES PURCHASE
AGREEMENT (the “Agreement”), dated as of September 3, 2024, is by and among Vuzix Corporation, a Delaware
corporation (the “Company”), and Quanta Computer Inc., a Taiwan corporation (the “Buyer”, collectively
with the Company, each a “Party” and together the “Parties”).
RECITALS
A. Subject to the terms and
conditions set forth in this Agreement, the Company desires to issue and sell to the Buyer, and the Buyer desires to purchase from the
Company, shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”) and shares of the
series B preferred stock of the Company, par value $0.001 per share (the “Series B Preferred Stock”), issued hereunder
and having the rights, preferences and privileges set forth in the Certificate of Designations in the form of Exhibit A hereto
(the “Certificate of Designations”). Each share of Series B Preferred Stock shall be initially convertible into ten
(10) shares of Common Stock pursuant to the terms and conditions set forth in the Certificate of Designations, subject to any further
adjustment(s) set forth therein.
B. The Buyer is agreeing to
purchase, and the Company is agreeing to sell, upon the terms and subject to the conditions stated in this Agreement, (i) at the First
Closing (as defined below), the First Closing Shares (as defined below), (ii) at the Second Closing (as defined below), the Second Closing
Shares (as defined below), and (iii) at the Third Closing (as defined below), the Third Closing Shares (as defined below), in no event
will the aggregate Common Stock and Series B Preferred Stock (on an as-converted basis) held by the Buyer (and its Affiliates, if applicable)
exceed 19.2% of total issued and outstanding shares or voting power of the Company at the date of each Closing on an as-converted basis
(the “Maximum Share Limitation”) (provided that, any shares held by Buyer (or its Affiliates, if applicable) but not
purchased from the Company under this Agreement (including, without limitation, any shares purchased in the open market) will be excluded
from the calculation of such ownership for purposes of the Maximum Share Limitation). “Affiliate” means any Person
that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person
as such terms are used in and construed under Rule 405 under the Securities Act (as defined below).
C. The offer and sale of the
Shares issuable hereunder will be made in reliance upon Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”), and the rules and regulations promulgated thereunder, or upon such other exemption from the registration requirements
of the Securities Act as may be available with respect to any or all of the transactions to be made hereunder.
AGREEMENT
NOW, THEREFORE, in consideration
of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the Company and the Buyer hereby agree as follows:
1. PURCHASE AND SALE
OF SHARES.
(a)
Purchase of Shares; Closings.
(i) First Closing. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 4 and 5 below, and subject
to the Maximum Share Limitation, the Company shall issue and sell to the Buyer, and the Buyer shall purchase from the Company at the First
Closing (as defined below) the number of Common Stock equal to the aggregate Purchase Price (as
defined below) of the First Closing divided by the Per Share Purchase Price (as defined below) of the First Closing (the “First
Closing Shares”). The closing (the “First Closing”) of the purchase of the First Closing Shares by
the Buyer shall occur on the fifteen (15th) Business Day after the conditions to the First Closing set forth in Sections 4
and 5 below are satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer). As used herein “Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Taiwan are
authorized or required by law to remain closed.
(ii) Second Closing. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 4 and 5 below, and subject
to the Maximum Share Limitation, the Company shall issue and sell to the Buyer, and the Buyer agrees to purchase from the Company at the
Second Closing (as defined below) the number of Series B Preferred Stock equal to the aggregate
Purchase Price (as defined below) of the Second Closing divided by the Per Share Purchase Price (as defined below) of the Second Closing
(the “Second Closing Shares”). The closing (the “Second Closing”) of the purchase of the
Second Closing Shares by the Buyer shall occur on the fifteen (15th) Business Day after the conditions to the Second Closing
set forth in Sections 4 and 5 below are satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer).
(iii) Third
Closing. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 4 and 5 below, and subject to the Maximum
Share Limitation, the Company shall issue and sell to the Buyer, and the Buyer agrees to purchase from the Company at the Third Closing
(as defined below) the number of Series B Preferred Stock equal to the Purchase Price (as defined
below) of the Third Closing divided by the Per Share Purchase Price (as defined below) of the Third Closing (the “Third Closing
Shares”, together with First Closing Shares and Second Closing Shares, the “Shares”). The closing
(the “Third Closing”) of the purchase of the Third Closing Shares by the Buyer shall occur on the fifteen (15th)
Business Day after the conditions to the Third Closing set forth in Sections 4 and 5 below are satisfied or waived (or such other date
as is mutually agreed to by the Company and the Buyer).
The First Closing, the Second Closing and the Third
Closing is each referred to herein as a “Closing,” and the date of each Closing is referred to herein as a “Closing
Date.”
(b)
Purchase Price. The purchase price per Share for the Shares to be purchased by the Buyer at each Closing (the “Per
Share Purchase Price”) shall be, (i) with respect to the First Closing, $1.30, (ii) with respect to the Second Closing, the
result of (A) the volume-weighted average sale price of the Common Stock on the Principal Market as reported by, or based upon data reported
by, Bloomberg during the thirty (30) Trading Days before the date on which the conditions to the Second Closing set forth in Sections
4 and 5 below are satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer) or $1.30, whichever is
higher, multiplied by (B) ten (10) and (iii) with respect to the Third Closing, the result of (A) the volume-weighted average sale price
of the Common Stock on the Principal Market reported by, or based upon data reported by, Bloomberg during the thirty (30) Trading Days
before the date on which the conditions to the Third Closing set forth in Sections 4 and 5 below are satisfied or waived (or such other
date as is mutually agreed to by the Company and the Buyer) or $1.30, whichever is higher, multiplied by (B) ten (10). “Trading
Day” means a day on which the Principal Market (as defined below) is open for trading. The Per Share Purchase Price shall be
automatically adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions that
occur with respect to the share capital of the Company after the date of this Agreement. The aggregate purchase price payable by the Buyer
(the “Purchase Price” of such Closing) shall be (i) $10,000,000 for the First Closing, (ii) $5,000,000 for the Second
Closing and (iii) $5,000,000 for the Third Closing, in each case subject to the Capital Cap (as defined below) for such Closing. In the
event that the Purchase Price for any Closing exceeds the Capital Cap for such Closing as a result of a decrease of total issued and outstanding
shares or voting power of the Company, such Purchase Price shall be reduced to the Capital Cap for such Closing. “Capital Cap”
of each Closing means the result of the Per Share Purchase Price of such Closing multiplied by the maximum number of Common Stock
(in the case of First Closing) or Series B Preferred Stock (in the case of Second Closing and Third Closing) to be issued to the Buyer
that would result in the Buyer (and its Affiliates, if applicable) meeting the Maximum Share Limitation after such issuance (considering
the shareholding of the Buyer at the time).
(c)
Form of Payment and Delivery. On the applicable Closing Date, (i) the Buyer shall pay the Purchase Price of such Closing
to the Company for the Shares to be issued and sold to the Buyer at the applicable Closing, by wire transfer of immediately available
funds and (ii) the Company shall (a) deliver, or cause the Company’s transfer agent to deliver, the First Closing Shares, registered
in the name of the Buyer (or an Affiliate of the Buyer as designated by the Buyer in writing) with the Company’s transfer agent
in book entry form, dated as of the First Closing Date, free and clear of all Liens (as defined below), (b) deliver, or cause the Company’s
transfer agent to deliver, a copy of the records of the transfer agent showing the Buyer (or an Affiliate of the Buyer as designated by
the Buyer in writing) as the registered owner of the First Closing Shares as of the First Closing Date, (c) deliver, or cause to be delivered
to the Buyer (or an Affiliate of the Buyer as designated by the Buyer in writing), one or more certificates evidencing the Second Closing
Shares and Third Closing Shares, as applicable, registered in the name of the Buyer (or an Affiliate of the Buyer as designated by the
Buyer in writing) as of the applicable Closing Date, and (d) evidence of the filing and acceptance of the Certificate of Designations
by the Secretary of State of the State of Delaware.
2. BUYER’S
REPRESENTATIONS AND WARRANTIES.
The Buyer represents and warrants
to the Company that, as of the date hereof and as of each Closing Date:
(a)
Organization; Authority. The Buyer is an entity duly organized, validly existing and in good standing under the laws of
the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the transactions contemplated
by this Agreement to which it is a party and otherwise to carry out its obligations hereunder.
(b)
No Public Sale or Distribution. The Buyer is acquiring its Shares for its own account and not with a view towards, or for
resale in connection with, the public sale or distribution thereof in violation of applicable securities laws, except pursuant to sales
registered or exempted under the Securities Act; provided, however, by making the representations herein, the Buyer does not agree, or
make any representation or warranty, to hold any of the Shares for any minimum or other specific term and reserves the right to dispose
of the Shares at any time in accordance with or pursuant to a registration statement or an exemption from registration under the Securities
Act. The Buyer does not presently have any agreement or understanding, directly or indirectly, with any Person to distribute any of the
Shares in violation of applicable securities laws. For purposes of this Agreement, “Person” means an individual, a
limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and
any Governmental Entity or any department or agency thereof.
(c)
Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of
Regulation D promulgated under the Securities Act “Regulation D”.
(d)
Reliance on Exemptions. The Buyer understands that the Shares are being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings
of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
Shares.
(e)
Information. The Buyer and its advisors, if any, have been furnished with all materials relating to the business, finances
and operations of the Company and materials relating to the offer and sale of the Shares that have been requested by the Buyer. The Buyer
and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor any other due
diligence investigations conducted by the Buyer or its advisors, if any, or its representatives shall modify, amend or affect the Buyer’s
right to rely on the Company’s representations and warranties contained herein. The Buyer understands that its investment in the
Shares involves a high degree of risk. The Buyer has sought such accounting, legal and tax advice as it has considered necessary to make
an informed investment decision with respect to its acquisition of the Shares.
(f)
No Governmental Review. The Buyer understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Shares or the fairness or suitability of the investment
in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the Shares.
(g)
Transfer or Resale. The Buyer understands that: (i) the Shares (and the shares of Common Stock issuable upon conversion
of the Series B Preferred Stock) have not been registered under the Securities Act or any state securities laws, and may not be offered
for sale, sold, assigned or transferred unless (A) subsequently registered thereunder, or (B) pursuant to an exemption from such registration.
(h)
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Buyer
and shall constitute the legal, valid and binding obligations of the Buyer enforceable against the Buyer in accordance with their respective
terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights
and remedies.
(i)
No Conflicts. The execution, delivery and performance by the Buyer of this Agreement and the consummation by the Buyer of
the transactions contemplated hereby will not (i) result in a violation of the organizational documents of the Buyer, or (ii) conflict
with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Buyer is a
party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws) applicable to the Buyer, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations
which could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Buyer
to perform its obligations hereunder.
3. REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.
The Company represents and
warrants to the Buyer that, as of the date hereof and as of each Closing Date:
(a)
Organization and Qualification. Each of the Company and each of its Subsidiaries are entities duly organized and validly
existing and in good standing under the laws of the jurisdiction in which they are formed, and have the requisite power and authority
to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted. Each of the Company
and each of its Subsidiaries is duly qualified to do business in all material aspects and is in good standing in all material aspects
in every jurisdiction in which its ownership of property or the nature of the business conducted by it makes such qualification necessary.
As used in this Agreement, “Subsidiaries” means any Person in which the Company, directly or indirectly, (I) owns any
of the outstanding capital stock or holds any equity or similar interest of such Person or (II) controls or operates all or any part of
the business, operations or administration of such Person, and each of the foregoing, is individually referred to herein as a “Subsidiary.”
(b) Authorization;
Enforcement; Validity. The Company has the requisite power and authority to enter into and perform its obligations under this
Agreement and to issue the Shares and the Common Stock issuable upon conversion of the Series B Preferred Stock in accordance with
the terms hereof. The execution and delivery of this Agreement by the Company, and the consummation by the Company of the
transactions contemplated hereby (including, without limitation, the issuance of the Shares and the Common Stock issuable upon
conversion of the Series B Preferred Stock) have been duly authorized by the Company’s board of directors (the
“Board”) or other governing body, as applicable, and other than any required filings with the SEC, and any other
filings as may be required by the Principal Market or any state securities agencies, no further filing, consent or authorization is
required by the Company, its Subsidiaries, their respective boards of directors or their stockholders or other governing body in
connection therewith. This Agreement has been duly executed and delivered by the Company, and constitutes the legal, valid and
binding obligations of the Company, enforceable against the Company in accordance with its respective terms, except as such
enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium,
liquidation or similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies
and except as rights to indemnification and to contribution may be limited by federal or state securities law.
(c)
Issuance of Shares. The issuance of the Shares is, and the Common Stock issuable upon conversion of the Series B Preferred
Stock will be, duly authorized and upon issuance in accordance with the terms of this Agreement the Shares will be validly issued, fully
paid and non-assessable and free from all preemptive, cosale, right of first refusal or similar rights, mortgages, defects, claims, liens,
pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances (collectively “Liens”)
with respect to the issuance thereof. All corporate action required to be taken for the authorization, issuance and sale of the Shares
and the Common Stock issuable upon conversion of the Series B Preferred Stock has been duly and validly taken. The Shares when issued,
and the shares of Common Stock issuable upon conversion of the Series B Preferred Stock, if and when issued, will have the terms and conditions
and entitle the holders thereof to the rights set forth in the Certificate of Incorporation (as defined below), as amended by the Certificate
of Designations. The maximum number of Common Stock initially issuable upon conversion of the Series B Preferred Stock have been duly
reserved for such issuance.
(d) No
Conflicts. The execution, delivery and performance of this Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby (including, without limitation, the issuance of the Shares and the Common Stock issuable upon
conversion of the Series B Preferred Stock) will not (i) result in a violation of the Certificate of Incorporation of the Company,
as amended (including, without limitation, any certificate of designation contained therein) (the “Certificate of
Incorporation”), the bylaws of the Company, as amended (the “Bylaws”), certificate of formation,
memorandum of association, articles of association, bylaws or other organizational documents of the Company, or any capital stock or
other securities of the Company, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) in any respect under, or give to others any rights of termination, amendment, acceleration or cancellation
of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is a party, or (iii) to the
Company’s knowledge, result in a violation of any law, rule, regulation, order, judgment or decree (including, without
limitation, foreign, federal and state securities laws and regulations and the rules and regulations of the Nasdaq Capital Market
(the “Principal Market”) and including all applicable foreign, federal and state laws, rules and
regulations) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its
Subsidiaries is bound or affected.
(e)
Consents. The Company is not required to obtain any consent, approval, authorization or order of, or make any declaration,
filing or registration with (other than any required filings with the SEC or the Principal Market, and any other filings as may be required
by any state securities agencies), any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other
Person in order for it to execute, deliver or perform any of its respective obligations under or contemplated by this Agreement in accordance
with the terms hereof. All consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant
to the preceding sentence have been or will be obtained or effected on or prior to each Closing Date, and the Company is not aware of
any facts or circumstances which might prevent the Company from obtaining or affecting any of the registration, application or filings
contemplated by this Agreement. The Company is not in violation of the requirements of the Principal Market and has no knowledge of any
facts or circumstances which could reasonably lead to delisting or suspension of the Common Stock in the foreseeable future. “Governmental
Entity” means any nation, state, county, city, town, village, district, or other political jurisdiction of any nature, federal,
state, local, municipal, foreign, or other government, governmental or quasi-governmental authority of any nature (including any governmental
agency, branch, department, official, or entity and any court or other tribunal), multi-national organization or body; or body exercising,
or entitled to exercise, any administrative, executive, judicial, legislative, police, regulatory, or taxing authority or power of any
nature or instrumentality of any of the foregoing, including any entity or enterprise owned or controlled by a government or a public
international organization or any of the foregoing.
(f)
No General Solicitation; Placement Agent’s Fees. Neither the Company, nor any of its Subsidiaries or Affiliates, nor
any Person acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of
Regulation D) in connection with the offer or sale of the Shares. There are no placement agent’s fees, financial advisory fees,
or brokers’ commissions that will be payable by the Company or any or its Subsidiaries or Affiliates relating to or arising out
of the transactions contemplated hereby, in connection with the sale of the Shares. The Company shall pay, and hold the Buyer harmless
against, any liability, loss or expense (including, without limitation, attorney’s fees and out-of-pocket expenses) arising in connection
with any such claim. Neither the Company nor any of its Subsidiaries has engaged any placement agent or other agent in connection with
the offer or sale of the Shares.
(g) No
Integrated Offering. None of the Company, its Subsidiaries or any of their Affiliates, nor any Person acting on their behalf
has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under
circumstances that would require registration of the issuance of any of the Shares and the Common Stock issuable upon conversion of
the Series B Preferred Stock under the Securities Act, whether through integration with prior offerings or otherwise. None of the
Company, its Subsidiaries, their Affiliates nor any Person acting on their behalf will take any action or steps that would require
registration of the issuance of any of the Shares and the Common Stock issuable upon conversion of the Series B Preferred Stock
under the Securities Act, cause the offering of any of the Shares and the Common Stock issuable upon conversion of the Series B
Preferred Stock to be integrated with other offerings of securities of the Company or cause this offering of the Shares and the
Common Stock issuable upon conversion of the Series B Preferred Stock to require approval of stockholders of the Company for
purposes of the Securities Act or under any applicable stockholder approval provisions, including, without limitation, under the
rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or
designated for quotation.
(h)
Application of Takeover Protections. The Company and the Board have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, interested stockholder, business combination, poison pill (including, without limitation,
any distribution under a rights agreement), stockholder rights plan or other similar anti-takeover provision under the Articles of Incorporation,
Bylaws or other organizational documents or the laws of the jurisdiction of its incorporation or otherwise which is or could become applicable
to the Buyer as a result of the transactions contemplated by this Agreement, including, without limitation, the Company’s issuance
of the Shares and the Common Stock issuable upon conversion of the Series B Preferred Stock and the Buyer’s ownership of the Shares
and the Common Stock issuable upon conversion of the Series B Preferred Stock. The Company and the Board have taken all necessary action,
if any, in order to render inapplicable any stockholder rights plan or similar arrangement relating to accumulations of beneficial ownership
of shares of Common Stock or Series B Preferred Stock or a change in control of the Company or any of its Subsidiaries.
(i) SEC
Documents; Financial Statements. The Company has timely filed all reports, schedules, forms, proxy statements, statements and
other documents required to be filed by it with Securities and Exchange Commission (the “Commission”) pursuant to
the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) in the past 36
months (all of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial
statements, notes and schedules thereto and documents incorporated by reference therein being hereinafter referred to as the
“SEC Documents”) or has received a valid extension of such time of filing and has filed any such SEC Documents
prior to the expiration of any such extension. None of the SEC Documents, at the time they were filed with the SEC, contained any
untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. As of their respective dates,
except as otherwise disclosed in the SEC Documents, the financial statements of the Company included in the SEC Documents complied
in all material respects with applicable accounting requirements and the published rules and regulations of the Commission with
respect thereto as in effect as of the time of filing. Such financial statements, when filed with the SEC, will have been prepared
in accordance with Generally Accepted Accounting Principles (“GAAP”), consistently applied, during the periods
involved (except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of
unaudited interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present
in all material respects the financial position of the Company as of the dates thereof and the results of its operations and cash
flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not
be material, either individually or in the aggregate). The reserves, if any, established by the Company or the lack of reserves, if
applicable, are reasonable based upon facts and circumstances known by the Company on the date hereof and there are no loss
contingencies that are required to be accrued by the Statement of Financial Accounting Standard No. 5 of the Financial Accounting
Standards Board which are not provided for by the Company in its financial statements or otherwise. No other information provided by
or on behalf of the Company to the Buyer which is not included in the SEC Documents contains any untrue statement of a material fact
or omits to state any material fact necessary in order to make the statements therein not misleading, in the light of the
circumstance under which they are or were made. The Company is not currently contemplating to amend or restate any of the financial
statements (including, without limitation, any notes or any letter of the independent accountants of the Company with respect
thereto) included in the SEC Documents (the “Financial Statements”), nor is the Company currently aware of facts
or circumstances which would require the Company to amend or restate any of the Financial Statements, in each case, in order for any
of the Financials Statements to be in compliance with GAAP and the rules and regulations of the SEC. The Company has not been
informed by its independent accountants that they recommend that the Company amend or restate any of the Financial Statements or
that there is any need for the Company to amend or restate any of the Financial Statements. The accountants who certified the
Financial Statements are independent public accountants as required by the Securities Act and the Exchange Act and the regulations
thereunder and the Public Company Accounting Oversight Board.
(j) Absence
of Certain Changes. Since June 30, 2024, except as disclosed in the SEC Documents, there has been no material adverse change and
no material adverse development in the business, assets, liabilities, properties, operations (including results thereof), condition
(financial or otherwise) or prospects of the Company or any of its Subsidiaries. Except for the transactions contemplated by this
Agreement, no event, liability or development, other than events, liabilities and developments in the ordinary course of business,
has occurred or exists with respect to the Company or its business, properties, operations or financial conditions that would be
required to be disclosed by the Company under applicable securities laws at the date hereof that has not been publicly disclosed at
least one (1) Business Day prior to the date hereof. Since June 30, 2024, except as disclosed in the SEC Documents, neither the
Company nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any assets, individually or in the aggregate,
outside of the ordinary course of business or (iii) made any capital expenditures, individually or in the aggregate, outside of the
ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to any
law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company or
any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary
bankruptcy proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so. The Company and its
Subsidiaries, individually and on a consolidated basis, are not as of the date hereof, and after giving effect to the transactions
contemplated hereby to occur at each Closing, will not be Insolvent (as defined below). For purposes of this Section 3(l),
“Insolvent” means, (i) with respect to the Company and its Subsidiaries, on a consolidated basis, (A) the present
fair saleable value of the Company’s and its Subsidiaries’ assets is less than the amount required to pay the
Company’s and its Subsidiaries’ total Indebtedness (as defined below), (B) the Company and its Subsidiaries are unable
to pay their debts and liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured
or (C) the Company and its Subsidiaries intend to incur or believe that they will incur debts that would be beyond their ability to
pay as such debts mature; and (ii) with respect to the Company and each Subsidiary, individually, (A) the present fair saleable
value of the Company’s or such Subsidiary’s (as the case may be) assets is less than the amount required to pay its
respective total Indebtedness, (B) the Company or such Subsidiary (as the case may be) is unable to pay its respective debts and
liabilities, subordinated, contingent or otherwise, as such debts and liabilities become absolute and matured or (C) the Company or
such Subsidiary (as the case may be) intends to incur or believes that it will incur debts that would be beyond its respective
ability to pay as such debts mature. Neither the Company nor any of its Subsidiaries has engaged in any business or in any
transaction, and is not about to engage in any business or in any transaction, for which the Company’s or such
Subsidiary’s remaining assets constitute unreasonably small capital with which to conduct the business in which it is engaged
as such business is now conducted and is proposed to be conducted. “Indebtedness” means (x) any indebtedness or other
obligation for borrowed money, whether current, short-term or long-term and whether secured or unsecured; (y) any indebtedness
evidenced by any note, bond, debenture or other security or similar instrument; (z) any liabilities with respect to interest rate or
currency swaps, collars, caps and similar hedging obligations; (xx) any liabilities in respect of any lease of (or other arrangement
conveying the right to use) real or personal property, or a combination thereof, which liabilities are required to be classified and
accounted for under GAAP as capital leases; (yy) any liabilities under any performance bond or letter of credit or any bank
overdrafts and similar charges; (zz) any accrued interest, premiums, penalties and other obligations relating to the foregoing items
in clauses (x) through (yy); and (xxx) any indebtedness referred to in clauses (x) through (zz) above of any Person that is either
guaranteed (including under any “keep well” or similar arrangement) by, or secured (including under any letter of
credit, banker’s acceptance or similar credit transaction) by any Lien upon any property or asset owned by, the Company or any
of its Subsidiaries.
(k) Conduct
of Business; Regulatory Permits. Neither the Company nor any of its Subsidiaries is in violation of any term of or in default
under its Articles of Incorporation, any certificate of designation, preferences or rights of any outstanding series of preferred
stock of the Company or any of its Subsidiaries or Bylaws or their organizational charter, certificate of formation, memorandum of
association, articles of association, Articles of Incorporation or certificate of incorporation or bylaws, respectively. Neither the
Company nor any of its Subsidiaries is in violation of any transnational, domestic or foreign federal, state or local law
(statutory, common or otherwise), constitution, treaty, convention, ordinance, code, rule (including stock exchange rules),
regulation, order, injunction, judgment, decree, ruling or other similar requirement applicable to the Company or any of its
Subsidiaries in any material manner, and neither the Company nor any of its Subsidiaries will conduct its business in violation of
any of the foregoing in all material aspects. The Subsidiaries of the Company are as disclosed in the SEC Documents. Without
limiting the generality of the foregoing, as of each Closing Date, the Company is not in violation of any of the rules, regulations
or requirements of the Principal Market and has no knowledge of any facts or circumstances that could reasonably lead to delisting
or suspension of the Common Stock by the Principal Market in the foreseeable future. As of each Closing Date, (i) the Common Stock
has been listed or designated for quotation on the Principal Market, (ii) trading in the Common Stock has not been suspended by the
Commission or the Principal Market and (iii) the Company has received no communication, written or oral, from the Commission or the
Principal Market regarding the suspension or delisting of the Common Stock from the Principal Market. The Company and each of its
Subsidiaries possess all material certificates, authorizations and permits issued by the appropriate regulatory authorities
necessary to conduct their respective businesses, and neither the Company nor any such Subsidiary has received any notice of
proceedings relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement,
commitment, judgment, injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any
of its Subsidiaries is a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing
any business practice of the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its
Subsidiaries or the conduct of business by the Company or any of its Subsidiaries as currently conducted. None of the Company and
any of its Subsidiaries is a “TID U.S. business,” as defined in 31 CFR § 800.248.
(l)
Equity Capitalization.
(i)
Authorized and Outstanding Capital Stock. As of the date hereof, the authorized capital stock of the Company consists of
(A) 100,000,000 shares of Common Stock, of which, 65,965,431 shares are issued and outstanding and 10,895,058 shares are reserved for
issuance pursuant to Convertible Securities (as defined below) exercisable or exchangeable for, or convertible into, shares of Common
Stock and (B) 5,000,000 shares of preferred stock, 49,626 of which have been designated series A preferred stock, 0 of which are issued
and outstanding and 800,000 shares of which have been designated Series B Preferred Stock, 0 which are currently issued and outstanding.
579,682 shares of Common Stock are held in the treasury of the Company. “Convertible Securities” means any capital
stock or other security of the Company or any of its Subsidiaries that is at any time and under any circumstances directly or indirectly
convertible into, exercisable or exchangeable for, or which otherwise entitles the holder thereof to acquire, any capital stock or other
security of the Company (including, without limitation, Common Stock) or any of its Subsidiaries.
(ii)
Valid Issuance. All of such outstanding shares are duly authorized and have been, or upon issuance will be, validly issued
and are fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and were not issued in
violation of or subject to any preemptive right or other rights to subscribe for or purchase securities. Except as disclosed in the SEC
Documents and this Section 3(l), there are no existing options, warrants, calls, subscriptions or other rights, agreements, arrangements
or commitments of any character, relating to the issued or unissued capital stock of the Company, obligating the Company to issue, transfer,
sell, redeem, purchase, repurchase or otherwise acquire or cause to be issued, transferred, sold, redeemed, purchased, repurchased or
otherwise acquired any capital stock or voting debt of, or other equity interest in, the Company or securities or rights convertible into
or exchangeable for such shares or equity interests or obligations of the Company to grant, extend or enter into any such option, warrant,
call, subscription or other right, agreement, arrangement or commitment.
(m)
Investment Company Status. The Company is not, and upon consummation of the sale of the Shares will not be or be required
to register as, an “investment company,” an Affiliate of an “investment company,” a company controlled by an “investment
company” or an “affiliated person” of, or “promoter” or “principal underwriter” for, an “investment
company” as such terms are defined in the Investment Company Act of 1940, as amended.
(n) Taxes. The Company has, in all material respects, filed on a timely basis (giving effect to extensions) all required federal,
state and foreign income and franchise tax returns and have timely paid or accrued all taxes shown as due thereon, including interest
and penalties and, to the knowledge of the Company, there is no tax deficiency that has been or might be asserted or threatened against
it or them in any material respects. All tax liabilities accrued through the date hereof have been adequately provided for on the books
of the Company. There are no Liens for material taxes upon the assets of the Company other than for current taxes not yet due and payable
or for taxes that are being contested in good faith by appropriate proceedings and for which adequate reserves in accordance with GAAP
has been made in the Company’s most recent Financial Statements included in the SEC Documents. On each Closing Date, all stock
transfer or other taxes (other than income or similar taxes) which are required to be paid in connection with the issuance, sale and
transfer of the Shares to be sold to the Buyer and issuance of the Common Stock issuable upon conversion of the Series B Preferred Stock
hereunder will be, or will have been, fully paid or provided for by the Company, and all laws imposing such taxes will be or will have
been complied.
(o)
No Registration. Assuming the accuracy of the Buyer’s representations and warranties set forth in Section 2, no registration
under the Securities Act is required for the offer and sale of the Shares by the Company to the Buyer or issuance of the Common Stock
issuable upon conversion of the Series B Preferred Stock as contemplated hereby. Other than the Buyer pursuant to the Registration Rights
Agreement, no Person has any right to cause the Company or any Subsidiary to effect the registration under the Securities Act of any securities
of the Company or any Subsidiary, except for such rights as have been duly waived or complied with.
(p)
Litigation. Except as disclosed in the SEC Documents, there are no material legal or governmental actions, suits or other
proceedings pending or, to the knowledge of the Company, threatened against the Company, before or by any court, regulatory body or administrative
agency or any other governmental agency or body, domestic or foreign. The Company is not a party to or subject to the provisions of any
material injunction, judgment, decree or order of any court, regulatory body, administrative agency or other governmental agency or body.
(q)
No “Bad Actor” Disqualification. No Disqualification Event described in Rule 506(d)(1)(i)-(viii) promulgated
under the Securities Act is applicable to the Company, or any Company Covered Person (as defined below) for purposes of Rule 506(d) under
the Securities Act, except, if applicable, for a Disqualification Event as to which Rule 506(d)(2)(ii) or (iii) or (d)(3) is applicable.
“Company Covered Person” means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated
under the Securities Act, any person listed in the first paragraph of Rule 506(d)(1).
(r)
Price of Common Stock. The Company has not taken, and will not take, directly or indirectly, any action designed to cause
or result in, or that has constituted or that might reasonably be expected to constitute, the stabilization or manipulation of the price
of the shares of the Common Stock to facilitate the sale or resale of the Shares, provided that, for the avoidance of doubt, this representation
will not be deemed to be breached by any release by the Company of press releases in the ordinary course of business consistent with past
practice.
(s) Employee Relations. No material labor dispute with the employees of the Company, or with the employees of any principal
supplier, manufacturer, customer or contractor of the Company, exists or, to the Company’s knowledge, is threatened or imminent.
No executive officer of the Company (as defined in Rule 501(f) promulgated under the Securities Act) has notified the Company that such
officer intends to leave the Company or otherwise terminate such officer’s employment with the Company. To the knowledge of the
Company, no executive officer of the Company is, or is now expected to be, in violation of any material term of any employment contract,
confidentiality, disclosure or proprietary information agreement, non-competition agreement, or any other agreement or any restrictive
covenant involving or otherwise affecting such executive officer’s relationship with the Company, and the continued employment
of each such executive officer does not subject the Company to any material liability with respect to any of the foregoing matters.
(t)
ERISA. The Company is in compliance in all material respects with all presently applicable provisions of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published interpretations thereunder (“ERISA”);
no “reportable event” (as defined in ERISA) has occurred with respect to any “pension plan” (as defined in ERISA)
for which the Company would have any material liability; the Company has not incurred or expects to incur material liability under
(a) Title IV of ERISA with respect to termination of, or withdrawal from, any “pension plan” or (b) Sections 412 or 4971 of
the Internal Revenue Code of 1986, as amended, including the regulations and published interpretations thereunder (the “Code”);
and each “Pension Plan” for which the Company would have liability that is intended to be qualified under Section 401(a) of
the Code is so qualified in all material respects and to the knowledge of the Company, nothing has occurred, whether by action or by failure
to act, which would cause the loss of such qualification.
(u)
Internal Control over Financial Reporting; Disclosure Controls. The Company maintains internal control over financial
reporting (as such term is defined in paragraph (f) of Rule 13a-15 under the Exchange Act) that are designed to comply with the requirements
of Rule 13a-15 under the Exchange Act. Since the end of the Company’s most recent audited fiscal year, except as disclosed in the
SEC Documents, there has been no material weakness in the design or operation of the Company’s internal control over financial reporting
(whether or not remediated) which are reasonably likely to adversely affect the Company’s ability to record, process, summarize
and report financial information. Since the end of the period covered by the most recently filed periodic report under the Exchange Act,
there have been no changes in the internal control over financial reporting (as such term is defined in the Exchange Act) of the Company
and its Subsidiaries that have materially adversely affected, or is reasonably likely to materially adversely affect, the internal control
over financial reporting of the Company and its Subsidiaries, except for remediation in material weakness disclosed in the Company’s
Form 10-K for the year ending December 31, 2023. The Company has established disclosure controls and procedures (as defined in Exchange
Act Rules 13a-15(e) and 15d-15(e)) for the Company and its Subsidiaries and designed such disclosure controls and procedures to ensure
that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed,
summarized and reported, within the time periods specified in the rules and forms of the Commission.
(v) Principal Market Compliance. The Common Stock is registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common
Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration.
The Company has not, in the previous twelve (12) months, received (a) written notice from the Principal Market that the Company is not
in compliance with the listing or maintenance requirements of the Principal Market that would result in immediate delisting or (b) any
notification, Staff Delisting Determination, or Public Reprimand Letter (as such terms are defined in applicable listing rules of the
Principal Market) that requires a public announcement by the Company of any noncompliance or deficiency with respect to such listing
or maintenance requirements. As of the date hereof and each Closing Date, (A) the Common Stock shall be designated for quotation or listed
(as applicable) on the Principal Market, (B) the Common Stock shall not have been suspended by the Commission or the Principal Market
from trading on the Principal Market and (C) trading of the Common Stock on the Principal Market shall not have been threatened to be
suspended by the Commission or the Principal Market (including through a written notification from the Principal Market indicating that
the closing bid price for Common Stock was below the minimum bid price), either (I) in writing by the Commission or the Principal Market
or (II) by falling below the minimum maintenance requirements of the Principal Market, provided that, in the event the Company does not
meet the minimum bid price requirement of the Principal Market, the representation specified in (C) will be deemed to be satisfied if,
through Board approval of a reverse split of the Common Stock (subject to such additional steps, including shareholder approval, as may
be required under applicable law to complete such reverse split), the Company has undertaken steps to regain compliance with such minimum
bid price requirement. Subject to the foregoing, the Company is in compliance with all listing and maintenance requirements (without
prejudice to the representation contained in other sentences of this Section 3(v), except the minimum bid price requirement) of the Principal
Market on the date hereof.
(w)
Compliance with Anti-Corruption Laws.
(i) None
of the Company, nor any of its director, agent, employee or any other Person acting for or on behalf of the Company (together, the “Covered
Persons”), has offered, promised, authorized or made, directly or indirectly, payments or other illegal inducements (regardless
of form, whether in money, property or services) to any (A) Public Official or (B) any other Person with the knowledge that all or any
portion of the money or thing of value will be offered or given to a Public Official, in each of the foregoing clauses (A)
and (B) for the purpose of influencing any action or decision of the Public Official in his
or her official capacity, including a decision to fail to perform his or her official duties, inducing the Public Official to use his
or her influence with any governmental authority to affect or influence any official act, or otherwise obtaining an improper advantage,
or (ii) to make or authorize any other Person to make any payments or transfers of value which have the purpose or effect of commercial
bribery, or acceptance or acquiescence in kickbacks or other unlawful or improper means of obtaining or retaining business, in each case,
in violation of applicable Anti-Corruption Laws. For purposes of the foregoing clauses (A) and (B), a Person shall be deemed to have
“knowledge” with respect to conduct, circumstances or results if such Person is aware of (i) the existence of or (ii) a high
probability of the existence of such conduct, circumstances or results. “Public Official” means any public or elected
official or officer, employee (regardless of rank), or person acting in an official capacity on behalf of a national, provincial, or
local government, including a department, agency, instrumentality, state-owned or state-controlled company, public international organization
(such as the United Nations or World Bank), or non-U.S. political party, non-U.S. party official or any candidate for political office.
Officers, employees (regardless of rank), or persons acting on behalf of an entity that is directly financed in large measure through
public appropriations or has its key officers and directors appointed by a government should also be considered “Public Officials.”
“Anti-Corruption Laws” means all applicable laws relating to anti-bribery, anti-corruption, record keeping and internal
control, including the U.S. Foreign Corrupt Practices Act of 1977, as amended, the UK Bribery Act of 2010, as amended, the relevant provisions
of the Criminal Law of the PRC effective on October 1, 1997, as amended, the PRC Anti-Unfair Competition Law effective on December 1,
1993, as amended, the Provisional Regulation on Anti-Commercial Bribery effective on November 15, 1996, as amended, and the Prevention
of Bribery Ordinance (Chapter 201 of the Laws of Hong Kong), as amended.
(ii) The
Company has adequate internal controls to ensure compliance by each Covered Person with all Anti-Corruption Laws, and have instituted
and maintain policies and procedures reasonably designed, together, (i) to ensure, and which are reasonably expected to continue to ensure,
continued compliance therewith, (ii) to maintain books, records and accounts which, in reasonable detail, accurately and fairly reflect
the transactions and dispositions of the assets of the Company, and (iii) to provide reasonable assurances that all transactions and
access to assets of the Company were, have been and are executed only in accordance with management’s general or specific authorization.
(iii) No
Covered Person has been the subject of any investigation, inquiry or enforcement proceedings by any governmental, administrative or regulatory
body or any customer regarding any offence under any Anti-Corruption Laws, and no such investigation, inquiry or enforcement proceedings
is pending or, to the best knowledge of the Company, threatened.
(x) Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance in all
material respects with all applicable Anti-Money Laundering Laws, and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is
pending or, to the best knowledge of the Company, threatened. The Company has implemented and shall maintain internal controls,
policies and procedures reasonably designed to ensure compliance by the Company with applicable Anti-Money Laundering Laws.
“Anti-Money Laundering Laws” means, with respect to any Person, all financial recordkeeping and reporting
requirements under the Applicable Laws relating to anti-money laundering and financing of terrorism, including those of the U.S.
Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by Providing Appropriate Tools Required to
Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), the Anti-Money Laundering and Counter-Terrorist Financing Ordinance
(Chapter 615 of the Laws of Hong Kong), as amended, and the applicable anti-money laundering statutes of jurisdictions where the
Person conducts business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued,
administered or enforced by any governmental agency.
(y)
Sanctions and Export Control Compliance.
(i) None of the Company, or any of its director, officer, or employee, or, to the knowledge of the Company, any agent, Affiliate or
representative of the Company, is a Sanctioned Person. “Sanctioned Person” means any Person (a) with whom dealings
are restricted, prohibited, or sanctionable under any Sanctions, including as a result of that Person’s: (1) being named on any
list of Persons subject to Sanctions, (2) being located, organized, or resident in, or directly or indirectly owned or controlled by the
government of, any Sanctioned Territory, or (3) having any direct or indirect relationship of ownership, control, or agency with, or any
direct or indirect commercial dealings with, a Person described in (1) or (2) or (b) who is subject to restrictions under any Export Control
Laws that are not generally applicable to Persons located in the same jurisdiction, including by reason of designation on a list of restricted
Persons (such as the United States Entity List, Unverified List, or Denied Persons List), status of the Person (such as a Military End
User under United States Export Control Laws), a relationship of ownership, control, or agency with any of the foregoing, or otherwise.
“Sanctioned Territory” means any country or territory with which dealings are broadly and comprehensively prohibited
by any country-wide or territory-wide Sanctions (as of the date hereof, Crimea, the so-called Donetsk People’s Republic and Luhansk
People’s Republic, Cuba, Iran, North Korea, and Syria). “Export Control Laws” means all laws relating to the
import, export, re-export, or transfer of information, data, goods, and technology, including the Export Administration Regulations administered
by the U.S. Department of Commerce, the International Traffic in Arms Regulations administered by the U.S. Department of State, and similar
laws of the PRC, the United Kingdom, and the European Union. “Sanctions” means all national and supranational laws,
regulations, decrees, orders, or other acts with force of law of the United States, the United Kingdom, the European Union, or the PRC,
or United Nations Security Council resolutions, concerning trade and economic sanctions including embargoes; the freezing or blocking
of assets of targeted Persons; or other restrictions on investment, payments, or other transactions targeted at particular Persons or
countries, including any laws threatening to impose such trade and economic sanctions on any Person for engaging in proscribed or targeted
behavior.
(ii) The
Company is, and for the past five (5) years has been, in compliance with applicable Sanctions and Export Control Laws in all material
respects, and is engaged in, or has in the past five (5) years been engaged in, any Sanctionable Activity. The Company has not been penalized
for, threatened in writing to be charged with, given written notice of, or to the knowledge of the Company, is or has been under investigation
by a governmental authority with respect to, any violation of any Sanctions or Export Control Laws. “Sanctionable Activity”
means any condition or activity that a reasonable person knowledgeable about the relevant Sanctions regime would conclude is specifically
identified under Sanctions as constituting a basis for the imposition of Sanctions against a person engaged in such activity or described
by such condition.
(iii) The Company has implemented and will maintain internal controls, policies and procedures reasonably designed to ensure compliance
by the Company and its directors, officers, employees, agents, Affiliates, and representatives with applicable Sanctions and Export Control
Laws.
(iv) The
Company has not in the past five (5) years engaged in, are not now engaged in, and will not engage in, any dealings or transactions in,
with, or relating to any Sanctioned Person or Sanctioned Territory, except any such transaction or dealing as (1) is permitted under
the laws and (2) does not constitute Sanctionable Activity.
(z)
Cybersecurity. The Company and its Subsidiaries’ information technology assets and equipment, computers, systems,
networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for,
and operate and perform in all material respects as required in connection with the operation of the business of the Company and its Subsidiaries
as currently conducted, and, to the Company’s knowledge, are free and clear of all material Trojan horses, time bombs, malware and
other malicious code. The Company and its Subsidiaries have implemented and maintained commercially reasonable physical, technical and
administrative controls designed to maintain and protect the confidentiality, integrity, availability, privacy and security of all sensitive,
confidential or regulated data (“Confidential Data”) used or maintained in connection with their businesses and Personal
Data (defined below), and the integrity, availability continuous operation, redundancy and security of all IT Systems. “Personal
Data” means the following data used in connection with the Company’s and its Subsidiaries’ businesses and in their
possession or control: (i) a natural person’s name, street address, telephone number, e-mail address, photograph, social security
number or other tax identification number, driver’s license number, passport number, credit card number, bank information, or customer
or account number; (ii) information that identifies, relates to, or may reasonably be used to identify an individual; (iii) any information
regarding an individual’s medical history, mental or physical condition, or medical treatment or diagnosis by a health care professional;
(iv) an individual’s health insurance policy number or subscriber identification number, any unique identifier used by a health
insurer to identify the individual, or any information in an individual’s application and claims history; (v) any information which
would qualify as “protected health information” under the Health Insurance Portability and Accountability Act of 1996, as
amended by the Health Information Technology for Economic and Clinical Health Act (collectively, “HIPAA”); (vi) any
information which would qualify as “personal data,” “personal information” (or similar term) under the Privacy
Laws (as defined below); and (vii) any other piece of information that alone, or combined with other information, allows the identification
of such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person’s
health or sexual orientation. To the Company’s knowledge, there have been no material breaches, outages or unauthorized uses of
or accesses to the Company’s IT Systems, Confidential Data, and Personal Data. The Company and its Subsidiaries are presently, and
at all prior times were, in material compliance with all applicable laws or statutes and all judgments and orders binding on the Company,
applicable binding rules and regulations of any court or arbitrator or governmental or regulatory authority, and their internal policies
and contractual obligations, each relating to the Processing (as defined below), privacy and security of Personal Data and Confidential
Data, the privacy and security of IT Systems and the protection of such IT Systems, Confidential Data, and Personal Data from unauthorized
use, access, misappropriation or modification.
(aa) Compliance with Data Privacy Laws. The Company and its Subsidiaries are, and at all prior times were, in material compliance
with all applicable state and federal data privacy and security laws and regulations regarding the collection, use, storage, retention,
disclosure, transfer, disposal, or any other processing (collectively “Process” or “Processing”)
of Personal Data, including HIPAA, the California Consumer Privacy Act, and the European Union General Data Protection Regulation (EU
2016/679) (collectively, the “Privacy Laws”). To ensure compliance with the Privacy Laws, the Company and its Subsidiaries
have in place, comply with, and take all appropriate steps necessary to ensure compliance in all material respects with their policies
and procedures relating to data privacy and security, and the Processing of Personal Data and Confidential Data (the “Privacy
Statements”). The Company and its Subsidiaries have, at all times since inception provided accurate notice of its Privacy Statements
then in effect to its customers, employees, third party vendors and representatives in all material respects. None of such disclosures
made or contained in any Privacy Statements have been materially inaccurate, misleading, incomplete, or in material violation of any
Privacy Laws. The Company further certifies that neither it nor any of its Subsidiaries (a) has received notice of any actual or potential
claim, complaint, proceeding, regulatory proceeding or liability under or relating to, or actual or potential violation of, any of the
Privacy Laws, contracts related to the Processing of Personal Data or Confidential Data, or Privacy Statements, and has no knowledge
of any event or condition that would reasonably be expected to result in any such notice, (b) is currently conducting or paying for,
in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law or contract, or (c) is a
party to any order, decree, or agreement that imposes any obligation or liability under any Privacy Law.
(bb) Transactions
With Affiliates and Employees. None of the officers or directors of the Company or any of its Subsidiaries and, to the knowledge
of the Company, none of the employees of the Company or any of its Subsidiaries is presently a party to any transaction with the Company
or any of its Subsidiaries (other than for services as employees, officers and directors), including any contract, agreement or other
arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from, providing
for the borrowing of money from or lending of money to or otherwise requiring payments to or from any officer, director or such employee
or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial interest or is
an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for (a) payment of salary,
bonus, consulting fees or other compensation for services rendered, (b) reimbursement for expenses incurred on behalf of the Company,
and (c) other employee benefits, including incentive award agreements under any incentive award plan of the Company.
4. CONDITIONS TO
THE COMPANY’S OBLIGATION TO SELL.
(a) The obligation of the Company hereunder to issue and sell the Shares to the Buyer at each Closing is subject to the satisfaction,
at or before the applicable Closing Date, of each of the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion by providing the Buyer with prior written notice thereof:
(i) The Buyer shall have executed the Registration Rights Agreement in the form attached hereto as Exhibit B (the “Registration
Rights Agreement”) and delivered the same to the Company.
(ii) The
Buyer shall have delivered to the Company the Purchase Price for such Closing by wire transfer of immediately available funds.
(iii)
The representations and warranties of the Buyer contained herein shall be true and correct in all material respects as of the date
when made and as of such Closing Date as though originally made at that time (except for representations and warranties that speak as
of a specific date, which shall be true and correct as of such specific date), and the Buyer shall have performed, satisfied and complied
in all material respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied
with by the Buyer at or prior to such Closing Date.
5. CONDITIONS TO
THE BUYER’S OBLIGATION TO PURCHASE.
(a) The
obligation of the Buyer hereunder to purchase the First Closing Shares at the First Closing is subject to the satisfaction, at or before
the First Closing Date, unless otherwise noted below, of each of the following conditions, provided that these conditions are for the
Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion by providing the Company with prior written
notice thereof:
(i) The
Parties shall have obtained any and all approvals, consents, decisions, clearances and waivers necessary for consummation of the transactions
contemplated by this Agreement, including, but not limited to, all permits, authorizations, approvals, consents or decisions of any Governmental
Entity or regulatory body;
(ii) The Company shall have duly executed and delivered to the Buyer the Registration Rights Agreement;
(iii)
The representations and warranties of the Company contained herein shall be true and correct as of the date when made and as of
each Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects
with the covenants, agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to such
Closing Date. The Buyer shall have received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of such
Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer;
(iv) The Company shall have delivered to the Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction
of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation dated as of a date within ten (10)
days prior to such Closing Date;
(v) As
of the First Closing Date, (A) the Common Stock shall be designated for quotation or listed (as applicable) on the Principal Market,
(B) the Common Stock shall not have been suspended by the Commission or the Principal Market from trading on the Principal Market
and (C) trading of the Common Stock on the Principal Market shall not have been threatened to be suspended by the Commission or the
Principal Market (including through a written notification from the Principal Market indicating that the closing bid price for
Common Stock was below the minimum bid price), either (I) in writing by the Commission or the Principal Market or (II) by falling
below the minimum maintenance requirements of the Principal Market, provided that, in the event the Company does not meet the
minimum bid price requirement of the Principal Market, the condition specified in (C) will be deemed to be satisfied if, through
Board approval of a reverse split of the Common Stock (subject to such additional steps, including shareholder approval, as may be
required under applicable law to complete such reverse split), the Company has undertaken steps to regain compliance with such
minimum bid price requirement;
(vi) The
Buyer shall have received a letter on the letterhead of the Company, duly executed by the Chief Executive Officer of the Company, setting
forth the wire transfer instructions of the Company;
(vii)
The Company shall have delivered to the Buyer the legal opinion of Sichenzia Ross Ference Carmel LLP, dated as of such Closing
Date with respect to matters customary for a private placement of this type, which form shall be reasonably agreed upon with the Buyer;
(viii) Since the date hereof, no event or series of events shall have occurred that has had or would reasonably be expected to have a
Material Adverse Effect. As used in this Agreement, “Material Adverse Effect” means any material adverse effect on
(i) the business, properties, assets, liabilities, operations (including results thereof), condition (financial or otherwise) or prospects
of the Company or any Subsidiary, individually or taken as a whole, (ii) the transactions contemplated hereby or any other agreements
or instruments to be entered into in connection herewith or (iii) the authority or ability of the Company or any of its Subsidiaries to
perform any of their respective obligations under this Agreement; and
(ix)
the Company shall have adopted and filed with the Secretary of State of the State of Delaware the Certificate of Designations in
the form of Exhibit A, and the Certificate of Designations shall have become effective as an amendment to the Certificate of Incorporation.
(b) The
obligation of the Buyer hereunder to purchase its Second Closing Shares at the Second Closing is subject to the satisfaction of the following
conditions, provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole
discretion by providing the Company with prior written notice thereof:
(i) The
Parties shall have obtained any and all approvals, consents, decisions, clearances and waivers necessary for consummation of the transactions
contemplated by this Agreement, including, but not limited to, all permits, authorizations, approvals, consents or decisions of any Governmental
Entity or regulatory body;
(ii) The First Closing shall have occurred;
(iii)
The representations and warranties of the Company contained herein shall be true and correct as of the date when made and as of
each Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects
with the covenants, agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to such
Closing Date. The Buyer shall have received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of such
Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer;
(iv) The Company shall have delivered to the Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction
of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation dated as of a date within ten (10)
days prior to such Closing Date;
(v) As
of the Second Closing Date, (A) the Common Stock shall be designated for quotation or listed (as applicable) on the Principal Market,
(B) the Common Stock shall not have been suspended by the Commission or the Principal Market from trading on the Principal Market and
(C) trading of the Common Stock on the Principal Market shall not have been threatened to be suspended by the Commission or the Principal
Market (including through a written notification from the Principal Market indicating that the closing bid price for Common Stock was
below the minimum bid price), either (I) in writing by the Commission or the Principal Market or (II) by falling below the minimum maintenance
requirements of the Principal Market, provided that, in the event the Company does not meet the minimum bid price requirement of the
Principal Market, the condition specified in (C) will be deemed to be satisfied if, through Board approval of a reverse split of the
Common Stock (subject to such additional steps, including shareholder approval, as may be required under applicable law to complete such
reverse split), the Company has undertaken steps to regain compliance with such minimum bid price requirement;;
(vi) The Waveguide Plate Production Capacity Rate (as defined in Exhibit C) at the Company’s Rochester waveguide plant
can be reasonably demonstrated to reach at least [**] per annum on a Sampled run-rate basis (as defined in Exhibit C) with Yield
Rates (as defined in Exhibit C), based on Waveguide Specification (as provided in Exhibit C), of [**] subject to Buyer receiving
proof reasonably acceptable to it and being offered reasonable access for inspection; The waveguide specification may be amended by mutual
agreement of the Parties from time to time;
(vii) The Company shall have delivered to the Buyer the legal opinion of Sichenzia Ross Ference Carmel LLP, dated as of such Closing
Date in customary form and substance to be reasonably agreed upon with the Buyer;
(viii) Since the date hereof, no event or series of events shall have occurred that has had or would reasonably be expected to have a
Material Adverse Effect;
(ix) The
aggregate issued and outstanding shares of Series B Preferred Stock (on an as-converted basis) and Common Stock held by the Buyer immediately
following the Second Closing shall not exceed the Maximum Share Limitation; and
(x) The Company has submitted a Listing of Additional Shares Notification Form to Nasdaq with respect to the shares of Common Stock
that are required to be initially reserved for issuance pursuant to Section 6(h) with respect
to Second Closing Shares, and Nasdaq has not raised any objection with respect to such form.
(c) The obligation of the Buyer hereunder to purchase its Third Closing Shares at the Third Closing is subject to the satisfaction
of the following conditions, provided that these conditions are for the Buyer’s sole benefit and may be waived by the Buyer at any
time in its sole discretion by providing the Company with prior written notice thereof:
(i) The Parties shall have obtained any and all approvals, consents, decisions, clearances and waivers necessary for consummation of
the transactions contemplated by this Agreement, including, but not limited to, all permits, authorizations, approvals, consents or decisions
of any Governmental Entity or regulatory body;
(ii) The
Second Closing shall have occurred;
(iii)
The representations and warranties of the Company contained herein shall be true and correct as of the date when made and as of
each Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific date,
which shall be true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects
with the covenants, agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to such
Closing Date. The Buyer shall have received a certificate, duly executed by the Chief Executive Officer of the Company, dated as of such
Closing Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer;
(iv) The Company shall have delivered to the Buyer a certificate evidencing the formation and good standing of the Company in its jurisdiction
of formation issued by the Secretary of State (or comparable office) of such jurisdiction of formation dated as of a date within ten (10)
days prior to such Closing Date;
(v) As
of the Third Closing Date, (A) the Common Stock shall be designated for quotation or listed (as applicable) on the Principal Market,
(B) the Common Stock shall not have been suspended by the Commission or the Principal Market from trading on the Principal Market
and (C) trading of the Common Stock on the Principal Market shall not have been threatened to be suspended by the Commission or the
Principal Market (including through a written notification from the Principal Market indicating that the closing bid price for
Common Stock was below the minimum bid price), either (I) in writing by the Commission or the Principal Market or (II) by falling
below the minimum maintenance requirements of the Principal Market, provided that, in the event the Company does not meet the
minimum bid price requirement of the Principal Market, the condition specified in (C) will be deemed to be satisfied if, through
Board approval of a reverse split of the Common Stock (subject to such additional steps, including shareholder approval, as may be
required under applicable law to complete such reverse split), the Company has undertaken steps to regain compliance with such
minimum bid price requirement;
(vi)
The Waveguide Plate Production Capacity Rate at the Company’s Rochester waveguide plant can be reasonably demonstrated to
reach or exceed [**] units per annum on a Sampled run-rate basis with Yield Rates, based on Waveguide Specification, of [**],
subject to Buyer receiving proof reasonably acceptable to it and being offered reasonable access for inspection;
(vii) The Company shall have delivered to the Buyer the legal opinion of Sichenzia Ross Ference Carmel LLP, dated as of such Closing
Date in customary form and substance to be reasonably agreed upon with the Buyer;
(viii) Since the date hereof, no event or series of events shall have occurred that has had or would reasonably be expected to have a
Material Adverse Effect;
(ix) The aggregate issued and outstanding shares of Series B Preferred Stock (on an as-converted basis) and Common Stock held by the
Buyer immediately following the Third Closing shall not exceed the Maximum Share Limitation; and
(x) The
Company has submitted a Listing of Additional Shares Notification Form to Nasdaq with respect to the shares of Common Stock that are
required to be initially reserved for issuance pursuant to Section 6(h) with respect to Third
Closing Shares, and Nasdaq has not raised any objection with respect to such form.
6. Covenants
(a)
Use of Proceeds. The Company shall use no less than $3,000,000 from the sale of the Shares for collaboration on Consumer
and Enterprise new generation product development associated with smart glasses for each Party’s needs and third-party consumers
utilizing waveguides of the Company.
(b)
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Shares in a manner that
would require the registration under the Securities Act of the sale of the Shares or that would be integrated with the offer or sale of
the Shares for purposes of the rules and regulations of any Principal Market such that it would require shareholder approval prior to
the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction.
(c) Legend
Removal. In connection with any sale, assignment, transfer or other disposition of the Shares of Common Stock (and shares issued
upon conversion of the Series B Preferred Stock) by the Buyer pursuant to Rule 144 or pursuant to any other exemption under the
Securities Act such that the purchaser acquires freely tradable shares and upon compliance by the Buyer with the requirements of
this Agreement, if requested by the Buyer by notice to the Company, the Company shall request, and take all commercially reasonable
steps to facilitate, the transfer agent of the Company (the “Transfer Agent”) to remove any restrictive legends
related to the book entry account holding such shares and make a new, unlegended entry for such book entry shares sold or disposed
of without restrictive legends within two (2) Business Days of any such request therefor from such Buyer, provided that the Company
has timely received from the Buyer customary representations and other documentation reasonably acceptable to the Company in
connection therewith. The Company shall be responsible for the fees of its Transfer Agent, its legal counsel and all DTC fees
associated with such legend removal. Subject to receipt from the Buyer by the Company and the Transfer Agent of customary
representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith, upon
the earliest of such time as the Shares (i) have been registered under the Securities Act pursuant to an effective registration
statement, (ii) have been sold pursuant to Rule 144, or (iii) are eligible for resale without volume limitations under Rule
144(b)(1) or any successor provision, the Company shall, in accordance with the provisions of this Section 6(c) and within two (2)
Business Days of any request therefor from the Buyer accompanied by such customary and reasonably acceptable documentation referred
to above, (A) deliver to the Transfer Agent irrevocable instructions that the Transfer Agent shall make a new, unlegended entry for
such book entry shares, and (B) cause its counsel to deliver to the Transfer Agent one or more opinions to the effect that the
removal of such legends in such circumstances may be effected under the Securities Act if required by the Transfer Agent to effect
the removal of the legend in accordance with the provisions of this Agreement. With respect to clause (i), while the registration
statement is effective, the Company shall cause its counsel, or counsel acceptable to the Transfer Agent, to issue to the Transfer
Agent a “blanket” legal opinion to allow the legend on the Shares to be removed upon resale of such shares pursuant to
the effective registration statement in accordance with this Section 6(c). Upon request, the Company shall provide the Buyer with
contact information for the person responsible for the Company’s account at the Transfer Agent to facilitate transfers made
pursuant to this Section 6(c). Any Shares subject to legend removal under this Section 6(c) may be transmitted by the Transfer Agent
to the Buyer by crediting the account of the Buyer’s prime broker with the DTC System as directed by the Buyer. The Company
shall be responsible for the fees of its Transfer Agent, its legal counsel and all DTC fees associated with such issuance.
(d) Disclosure
of Transactions. The Company shall, within the time period required under the Exchange Act, file with the Commission a Current
Report on Form 8-K (the “Disclosure Document”) disclosing all material terms of the transactions contemplated by
this Agreement and the Registration Rights Agreement and including this Agreement and the Registration Rights Agreement as exhibits
to such Current Report on Form 8-K. Upon the filing of the Disclosure Document, to the knowledge of the Company, the Buyer shall be
in no possession of any material, non-public information received from the Company or any of its officers, directors, or employees
or agents, that is not disclosed in the Disclosure Document unless otherwise specifically agreed in writing by the Buyer.
Notwithstanding anything in this Agreement to the contrary, the Company shall not, without the prior written consent of the Buyer,
publicly disclose the name of the Buyer or any of its Affiliates or advisers, or include the name of the Buyer or any of its
Affiliates or advisers in (i) marketing materials or (ii) any filing with the Commission or any regulatory agency, except with
respect to clause (ii) as required by the federal securities law including without limitation, in connection with (A) any
registration statement contemplated by the Registration Rights Agreement and (B) the Disclosure Document, including without
limitation, the filing of this Agreement and the Registration Rights Agreement (including signature pages thereto) with the
Commission or pursuant to other routine proceedings of regulatory authorities or to the extent such disclosure is required by law,
at the request of the staff of the Commission or regulatory agency or under the regulations of the Principal Market, in which case,
with respect to the Disclosure Document, the Company will provide the Buyer with prior written notice (including by e-mail) and
opportunity to review such disclosure under this clause (ii).
(e)
Material Non-Public Information. The Company has not provided the Buyer with any information that will constitute material
non-public information, except insofar as the existence, provisions and terms of the Agreement and other transaction documents and the
proposed transactions hereunder may constitute such information. From and after the issuance of the Disclosure Document as set forth in
Section 6(d), the Company represents to the Buyer that it shall have publicly disclosed all material, non-public information delivered
to the Buyer by the Company or any of its officers, directors, employees or agents in connection with the transactions contemplated by
this Agreement. The Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide the Buyer or
its agents or counsel with any information that constitutes, or the Company reasonably believes constitutes, material non-public information
without the Buyer’s consent. To the extent that the Company delivers any material, non-public information to the Buyer without the
Buyer’s consent, the Company hereby covenants, or to the extent that any notice provided pursuant to this Agreement constitutes,
or contains, material, non-public information regarding the Company, the Company shall simultaneously file such notice with the Commission
pursuant to a Current Report on Form 8-K. The Company understands and confirms that the Buyer and its Affiliates will rely on the foregoing
representations in effecting transactions in securities of the Company.
(f)
Indemnification. Subject to the provisions of this Section 6(f) and Section 7, the Company agrees to indemnify and hold
harmless the Buyer and its Affiliates, and the Buyer’s and its Affiliates’ respective directors, officers, trustees, members,
managers, employees and agents, from and against any and all losses, claims, damages, liabilities and out-of-pocket expenses, including
reasonable and documented attorney fees and disbursements and other documented out-of-pocket expenses reasonably incurred in connection
with investigating, preparing or defending any action, claim or proceeding, pending or threatened and the costs of enforcement thereof
(collectively, “Losses”), to which such Person may become subject as a result of or relating to any breach of representation
or warranty, covenant or agreement made by or to be performed on the part of the Company under this Agreement, and will reimburse any
such Person for all such amounts as they are incurred by such Person.
(g) Listing
Status. For as long as the Buyer holds any Shares, the Company shall take all necessary actions to cause the Common Stock
to remain listed or designated for quotation on the Principal Market and trading in the Common Stock not to be suspended by the
Commission or the Principal Market, including considering all available options to comply with the continued listing standards of
the Principal Market, including, but not limited to, a reverse stock split, subject to stockholder approval.
(h) Conversion
Shares. The Company will reserve and keep available at all times, free of preemptive or similar rights, shares of Common Stock as
required pursuant to Section 8 of the Certificate of Designations.
(i)
Joint Voluntary Notification.
The Parties agree to consult
and determine in good faith as expeditiously as possible whether a Joint Voluntary Notice(“JVN”) or short-form Declaration
(“Declaration”) of the transactions contemplated by this Agreement to CFIUS under the DPA is desirable and should be filed.
If either Party determines in its sole discretion that such a JVN or Declaration should be filed, the Parties shall use commercially reasonable
efforts to (i) take the CFIUS Filing Actions and the CFIUS Cooperation Actions, (ii) respond as promptly as practicable, and no later
than the deadline specified by CFIUS for such a response, to any information request from CFIUS in connection with the CFIUS assessment,
review or investigation of the transactions contemplated by this Agreement, and (iii) obtain the CFIUS Clearance as promptly as practicable,
provided that for the avoidance of doubt, commercially reasonable efforts under clauses (i) to (iii) shall not require either Party to
accept any proposed mitigation agreement that would have an adverse economic impact on such Party.
For the purpose of this
Agreement, “CFIUS” means the Committee on Foreign Investment in the United States or any successor entity, and
any member agency thereof acting in such capacity. “CFIUS Clearance” means the Parties shall have received (a) a
written notice issued by CFIUS stating that CFIUS has concluded that the transactions contemplated by this Agreement is not a
“covered transaction” and not subject to review under applicable law, (b) a written notice issued by CFIUS that it has
determined that there are no unresolved national security concerns with respect to the transactions contemplated by this Agreement,
and has concluded all actions under the DPA or (c) either (i) the President of the United States shall have determined not to use
his powers pursuant to the DPA to unwind, suspend, condition or prohibit the consummation of the transactions contemplated by this
Agreement or (ii) the period allotted for presidential action under the DPA shall have passed without any determination by the
President. “CFIUS Cooperation Actions” shall mean each Party to this Agreement shall promptly inform the other,
unless prohibited by applicable law, of any communication from CFIUS or its member agencies regarding any of the transactions
contemplated by this Agreement in connection with any CFIUS filing. In connection with and without limiting the foregoing, to the
extent reasonably practicable and unless prohibited by applicable law, each Party shall (i) give each other reasonable advance
notice of all meetings with CFIUS or its member agencies relating to the transaction contemplated hereby, (ii) give each other an
opportunity to participate in each of such meetings, (iii) keep such other Party reasonably apprised with respect to any oral
communications with CFIUS regarding the transaction contemplated hereby, (iv) cooperate in the filing of any joint CFIUS notice and
any presentations related thereto, (v) provide each other with a reasonable advance opportunity to review and comment upon, and
consider in good faith the views of the other with respect to, all written communications with CFIUS, except for those that may
include confidential business information or involve personal identifier information and (vi) provide each other (or counsel of each
Party, as appropriate) with copies of all written communications to or from CFIUS, except for those excluded above. Any such
disclosures, rights to participate or provisions of information by one Party to the other may be made on a counsel-only basis to the
extent required under applicable law or as appropriate to protect confidential business information. “CFIUS Filing
Actions” shall mean the Parties to this Agreement submit or cause to be submitted (i) a voluntary notice of the
transaction to CFIUS within the meaning of 31 C.F.R. §800.402 to obtain a CFIUS Clearance, and (ii) as soon as possible (and in
any event in accordance with pertinent regulatory requirements) any other submissions that are formally requested by CFIUS to be
made, or which the Parties mutually agree should be made, in each case in connection with this Agreement and the transaction
contemplated hereby. “DPA” shall mean Section 721 of the U.S. Defense Production Act of 1950, as amended,
including the implementing regulations thereof, codified at 31 C.F.R. Parts 800 and 801.
7. Termination.
(a)
This Agreement shall terminate at any time prior to the Third Closing (i) by mutual written agreement of the Company and the Buyer,
(ii) by either Party, if the Second Closing has not occurred within twelve (12) months after the date of this Agreement and (iii) by either
Party, if the Third Closing has not occurred within eighteen (18) months after the date of this Agreement; provided that a Party
in material breach of this Agreement shall not be permitted to terminate pursuant to this Section.
(b) If this Agreement is terminated as permitted by Section 7(a), such termination
shall be without liability of either Party (or any shareholder, director, officer, employee, agent, consultant or representative of such
Party) to the other Parties to this Agreement; provided that if such termination shall result from the (i) willful failure of either Party
to fulfill a condition to the performance of the obligations of the other Party, (ii) failure to perform a covenant of this Agreement
or (iii) breach by either Party of any representation or warranty or agreement contained herein, such Party shall be fully liable for
any and all Losses incurred or suffered by the other Party as a result of such failure or breach excluding any shareholder, director,
officer, employee, agent, consultant or representative of such Party. The provisions of this
Section 7 and Section 8 shall survive any termination hereof. Notwithstanding anything to the contrary, if this Agreement is terminated
pursuant to Section 7(a) after any Closing, the provisions hereof relating to such Closing,
including the rights provided in Registration Rights Agreement, shall survive such termination.
8. MISCELLANEOUS.
(a)
Governing Law; Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law
provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions
other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts
sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with
any transaction contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim
that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process
and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for
such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.
(b) Counterparts.
This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to the other party. In the event that any
signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file of an
executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.
(c)
Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include
the masculine, feminine, neuter, singular and plural forms thereof. The terms “including,” “includes,” “include”
and words of like import shall be construed broadly as if followed by the words “without limitation.” The terms “herein,”
“hereunder,” “hereof” and words of like import refer to this entire Agreement instead of just the provision in
which they are found.
(d) Severability. If any provision of this Agreement is prohibited by law or otherwise determined to be invalid or unenforceable
by a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Agreement so long as this Agreement as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).
(e) Entire
Agreement; Amendments. This Agreement and the schedules and Exhibits attached hereto and thereto and the instruments referenced herein
supersede all other prior oral or written agreements between the Buyer, the Company, its Subsidiaries, their Affiliates and Persons acting
on their behalf, and the other matters contained herein and therein, and this Agreement, the schedules and Exhibits attached hereto and
the instruments referenced herein contain the entire understanding of the parties solely with respect to the matters covered herein and
therein; provided, however, nothing contained in this Agreement shall (or shall be deemed to) waive, alter, modify or amend in any respect
any obligations of the Company or any of its Subsidiaries, or any rights of or benefits to the Buyer or any other Person, in any agreement
entered into prior to the date hereof between or among the Company and/or any of its Subsidiaries and the Buyer, or any instruments the
Buyer received from the Company and/or any of its Subsidiaries prior to the date hereof, and all such agreements and instruments shall
continue in full force and effect. Except as specifically set forth herein or therein, neither the Company nor the Buyer makes any representation,
warranty, covenant or undertaking with respect to such matters. For clarification purposes, the Recitals are part of this Agreement.
No provision of this Agreement may be amended other than by an instrument in writing signed by the Company and the Buyer. No waiver shall
be effective unless it is in writing and signed by an authorized representative of the waiving party.
(f) Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must be
in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by
facsimile (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending party)
or electronic mail (provided that such sent email is kept on file (whether electronically or otherwise) by the sending party and the
sending party does not receive an automatically generated message from the recipient’s email server that such e-mail could not
be delivered to such recipient); or (iii) one (1) Business Day after deposit with an overnight courier service with next day
delivery specified, in each case, properly addressed to the party to receive the same. The addresses, facsimile numbers and e-mail
addresses for such communications shall be:
If to the Company:
Vuzix Corporation
25 Hendrix Road
West Henrietta, New York 14586
Telephone: 585-359-5900
Attention: General Counsel
E-Mail: Legal@vuzix.com
With a copy (for informational purposes only) to:
Sichenzia Ross Ference Carmel LLP
1185 Avenue of the Americas, 31st Floor
New York, NY 10036
Telephone: (212) 930-9700
Facsimile: (212) 930-9725
Attention: Gregory Sichenzia, Esq.
E-Mail: gsichenzia@srfc.law
If to the Buyer:
Quanta Computer Inc.
211, Wen Hwa 2nd Rd., Kueishan
Taoyuan 33377, Taiwan
Telephone:
Attention:
E-Mail:
with a copy (for informational purposes only) to:
Davis Polk & Wardwell LLP
Address: 10th Floor, The Hong Kong
Club Building
3A Chater Road, Hong Kong
Attention: James C. Lin
E-Mail: james.lin@davispolk.com
or to such other address, e-mail address and/or facsimile number and/or
to the attention of such other Person as the recipient party has specified by written notice given to each other party five (5) days prior
to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent, waiver or other
communication, (B) mechanically or electronically generated by the sender’s facsimile machine or e-mail containing the time, date,
recipient facsimile number and, with respect to each facsimile transmission, an image of the first page of such transmission or (C) provided
by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile or receipt from an overnight courier
service in accordance with clause (i), (ii) or (iii) above, respectively.
(g) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and permitted assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder
without the prior written consent of the other party; provided that the Buyer may, without the prior consent of the Company, assign any
of its rights hereunder (including right to purchase the Shares) to any of its Affiliates but no such assignment shall relieve the Buyer
from its obligations or liability pursuant to this Agreement unless otherwise specifically agreed to by the Company.
(h) No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.
(i)
Survival. The representations, warranties, agreements and covenants shall survive each Closing.
(j)
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things,
and shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.
(k) Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express their
mutual intent, and no rules of strict construction will be applied against any party. No specific representation or warranty shall limit
the generality or applicability of a more general representation or warranty. Each and every reference to share prices, shares of Common
Stock or Series B Preferred Stock and any other numbers in this Agreement that relate to the Common Stock or Series B Preferred Stock
shall be automatically adjusted for any stock splits, stock dividends, stock combinations, recapitalizations or other similar transactions
that occur with respect to the share capital of the Company after the date of this Agreement. Notwithstanding anything in this Agreement
to the contrary, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty against, or a prohibition
of, any actions with respect to the borrowing of, arrangement to borrow, identification of the availability of, and/or securing of, securities
of the Company in order for the Buyer (or its broker or other financial representative) to effect short sales or similar transactions
in the future.
[signature pages follow]
IN WITNESS WHEREOF, the
Buyer and the Company have caused their respective signature page to this Agreement to be duly executed as of the date first written above.
|
COMPANY: |
|
|
|
|
VUZIX CORPORATION |
|
|
|
|
By: |
/s/ Paul Travers |
|
Name: |
Paul Travers |
|
Title: |
Chief Executive Officer |
|
BUYER: |
|
|
|
|
Quanta Computer Inc. |
|
|
|
|
By: |
/s/ C. C. Leung |
|
Name: |
C. C. Leung |
|
Title: |
Vice Chairman |
Exhibit A
Certificate of Designations of Series B Preferred
Stock
Exhibit B
Registration Rights Agreement
Exhibit C
The term “Waveguide Plate Production Capacity Rate”
is intended to mean [**]
Exhibit 10.2
REGISTRATION RIGHTS AGREEMENT
This REGISTRATION RIGHTS AGREEMENT (the “Agreement”)
is made as of September 3, 2024 by and among Vuzix Corporation, a Delaware corporation (the “Company”), and Quanta
Computer Inc., a Taiwan corporation (the “Purchaser”).
RECITALS
WHEREAS, the Company and the Purchaser are parties
to a Securities Purchase Agreement, dated as of September 3, 2024 (as amended from time to time, the “Purchase Agreement”),
pursuant to which the Purchaser is purchasing (i) shares of Common Stock (as defined below) and (ii) shares of Series B
Preferred Stock (as defined below) of the Company; and
WHEREAS, in connection with the consummation of
the transactions contemplated by the Purchase Agreement, and pursuant to the terms of the Purchase Agreement, the parties desire to enter
into this Agreement in order to grant certain rights to the Purchaser as set forth below.
NOW, THEREFORE, in consideration of the covenants
and promises set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
the parties hereby agree as follows:
AGREEMENT
1. Certain
Definitions.
Unless the context otherwise requires, the following
terms, for all purposes of this Agreement, shall have the meanings specified in this Section 1. Capitalized terms used and not otherwise
defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase Agreement.
“Agreement” has the meaning
set forth in the recitals.
“Allowed Delay” has the meaning
set forth in Section 2.1(b)(ii).
“Board” means the board of
directors of the Company.
“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Taiwan are
authorized or required by law to remain closed.
“Common Stock” means shares
of the common stock of the Company, par value $0.001 per share.
“Company” has the meaning set
forth in the recitals.
“Effectiveness Deadline” means,
with respect to the Shelf Registration Statement or New Registration Statement, the sixtieth (60th) calendar day following the First
Closing Date (or, in the event the SEC reviews and has comments to the Shelf Registration Statement or the New Registration Statement,
the ninetieth (90th) calendar day following the First Closing Date); provided, however, that if the Company is notified
by the SEC (either orally or in writing, whichever is earlier) that the Shelf Registration Statement or the New Registration Statement
will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Shelf Registration
Statement shall be the fifth (5th) Business Day following the date on which the Company is so notified if such date precedes the dates
otherwise required above; provided, further, that if the Effectiveness Deadline falls on a Saturday, Sunday or other day
that the SEC is closed for business, the Effectiveness Deadline shall be extended to the next Business Day on which the SEC is open for
business; provided, further, that if the SEC is closed for operations due to a government shutdown or lapse in appropriations,
the Effectiveness Deadline shall be extended by the same amount of days that the SEC remains closed for operations.
“Effectiveness Period” has
the meaning set forth in Section 2.1(b)(i).
“Exchange Act” means the Securities
Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated thereunder.
“Filing
Deadline” means forty-five (45) days following the First Closing Date, and, with respect to any additional Registration
Statements which may be required pursuant to Section 2.3(p), the earliest practical date on which the Company is permitted by SEC
Guidance to file such additional Registration Statement related to the Registrable Securities.
“FINRA” means the Financial
Industry Regulatory Authority.
“Form S-3” means such
form under the Securities Act as in effect on the date hereof or any successor or similar registration form under the Securities Act
subsequently adopted by the SEC that permits inclusion or incorporation of substantial information by reference to other documents filed
by the Company with the SEC.
“Free Writing Prospectus” means
an issuer free writing prospectus, as defined in Rule 433 under the Securities Act, relating to an offer of Registrable Securities.
“Holder” means the holder or
holders, as the case may be, from time to time of the Registrable Securities.
“Losses” has the meaning set
forth in Section 2.5(a).
“New Registration Statement”
has the meaning set forth in Section 2.1(a).
“Participating Holder” means
with respect to any registration, any Holder of Registrable Securities covered by the applicable Registration Statement.
“Prospectus” means the prospectus
included in any Registration Statement (including a prospectus that discloses information previously omitted from a prospectus filed
as part of an effective Shelf Registration Statement in reliance upon Rule 430A or Rule 430B promulgated under the Securities
Act), all amendments and supplements to such prospectus, including pre- and post-effective amendments to such Registration Statement,
and all other material incorporated by reference in such prospectus.
“Purchase Agreement” has the
meaning set forth in the recitals.
“Register,” “registered”
and “registration” refer to a registration effected by preparing and filing a registration statement in compliance
with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document.
“Registrable Securities” means
(i) the Shares and (ii) any Common Stock issued as a dividend or other distribution with respect to, or in exchange for or
in replacement of, Shares. Notwithstanding the foregoing, Shares or any such Common Stock, as applicable, shall cease to be Registrable
Securities for all purposes hereunder upon the earliest to occur of the following: (a) the sale by any Person of such Shares or
any such Common Stock, as applicable, either pursuant to a registration statement under the Securities Act or under Rule 144 (or
any similar provision then in effect) (in which case, only such Shares or any such Common Stock, as applicable, sold shall cease to be
Registrable Securities), (b) such Shares shall have been otherwise transferred, new certificates (or book entry issuance, as applicable)
for such Shares not bearing a legend restricting further transfer shall have been delivered by Company and subsequent public distribution
of such Shares shall not require registration under the Securities Act, (c) such Shares cease to be outstanding, or (d) such
securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities transaction.
“Registration Statement” means
any registration statement of the Company that covers the resale of any of the Registrable Securities pursuant to the provisions of this
Agreement filed with, or to be filed with, the SEC under the rules and regulations promulgated under the Securities Act, including
the related Prospectus, amendments and supplements to such registration statement, including pre- and post-effective amendments, and
all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.
“Remainder Registration Statement”
has the meaning set forth in Section 2.1(a).
“Rule 144” means Rule 144
as promulgated by the SEC under the Securities Act, as such rule may be amended from time to time, or any similar successor rule that
may be promulgated by the SEC having substantially the same effect as such Rule.
“SEC” means the Securities
and Exchange Commission or any other federal agency at the time administering the Securities Act.
“SEC Guidance” means any publicly-available
written or oral guidance, comments, requirements or requests of the SEC staff under the Securities Act; provided, that any such
oral guidance, comments, requirements or requests are reduced to writing by the SEC.
“Securities Act” means the
Securities Act of 1933, as amended, or any similar successor federal statute and the rules and regulations thereunder, all as the
same shall be in effect from time to time.
“Series B Preferred Shares”
means the shares of Series B Preferred Stock issued or issuable to the Purchaser and/or its Affiliates pursuant to the Purchase
Agreement.
“Series B Preferred Stock”
means the shares of the Series B Preferred Stock, par value $0.001 of the Company.
“Shares” means all of the (i) shares
of Common Stock issued or issuable to the Purchaser and/or its Affiliates pursuant to the Purchase Agreement and (ii) shares of
Common Stock issuable upon conversion of the Series B Preferred Shares.
“Shelf Registration Statement”
has the meaning set forth in Section 2.1(a).
“Transaction Agreements” means
this Agreement and the Purchase Agreement, all exhibits and schedules thereto and hereto and any other documents or agreement executed
in connection with the transactions contemplated hereunder or thereunder.
2. Registration
Rights.
2.1 Shelf
Registration.
(a) Registration
Statements. On or prior to the Filing Deadline, the Company shall use commercially reasonable efforts to prepare and file with the SEC
a Registration Statement on Form S-3, subject to the provisions of Section 2.1(d), for the resale of all of the Registrable
Securities pursuant to an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act (the “Shelf
Registration Statement”). Such Shelf Registration Statement shall include the aggregate amount of Registrable Securities to
be registered therein and shall contain (except if otherwise required pursuant to written comments received from the SEC upon a review
of such Shelf Registration Statement) the “Plan of Distribution” substantially in the form of Annex A (which may be
modified to respond to comments, if any, provided by the SEC). To the extent the staff of the SEC does not permit all of the Registrable
Securities to be registered on the Shelf Registration Statement filed pursuant to this Section 2.1(a) or for any other reason
any Registrable Securities are not then included in a Registration Statement filed under this Agreement, the Company shall (i) inform
each of the Participating Holders thereof and use its commercially reasonable efforts to file amendments to the Shelf Registration Statement
as required by the SEC, and/or (ii) withdraw the Shelf Registration Statement and file a new registration statement (a “New
Registration Statement”), in either case covering the maximum number of Registrable Securities permitted to be registered by
the SEC, on Form S-3 or such other form available to register for resale the Registrable Securities as a secondary offering. Notwithstanding
any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities permitted
to be registered on a particular Registration Statement as a secondary offering, unless otherwise directed in writing by a Holder as
to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement will be reduced on
a pro rata basis based on the total number of unregistered Shares held by such Holders. In the event the Company amends the Shelf Registration
Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use
its commercially reasonable efforts to file with the SEC, as promptly as allowed by the SEC or SEC Guidance provided to the Company or
to registrants of securities in general, one or more Registration Statements on Form S-3 or such other form available to register
for resale those Registrable Securities that were not registered for resale on the Shelf Registration Statement, as amended, or the New
Registration Statement (the “Remainder Registration Statement”). In no event shall any Participating Holder be identified
as a statutory underwriter in the Registration Statement unless in response to a comment or request from the staff of the SEC or another
regulatory agency; provided, however, that if the SEC requests that a Participating Holder be identified as a statutory
underwriter in the Registration Statement, such Holder will have an opportunity to withdraw from the Registration Statement.
(b) Underwritten
Offerings.
(i) So
long as the Registration Statement remains in effect, each Participating Holder shall have the right at any time or from time to time
to elect to sell Registrable Securities pursuant to an offering (including pursuant to an underwritten offering (an “Underwritten
Offering”)); provided, however, that the aggregate amount of Registrable Securities included in any such Underwritten Offering
must be at least the lesser of the amount reasonably expected to result in gross proceeds of $five (5) million and the remainder
of the Registrable Securities held by such Holder. The applicable Holders shall make such election by delivering to the Company a written
request (a “Shelf Offering Request”) for such offering specifying the number of Shelf Registrable Securities that
such Holders desire to sell pursuant to such offering (the “Shelf Offering”). The Company shall, as expeditiously
as possible, use its commercially reasonable efforts to facilitate such Shelf Offering and shall pay all reasonable registration expenses
in connection to the offering. The Company shall not be obligated to effect more than one (1) underwritten Shelf Offering in any
six (6) month period under this Section 2.1(b) unless the Company otherwise consents. A Shelf Offering may be in the form
of a block or bought trade (a “Block Trade”), including as an underwritten Block Trade so long as the Company is eligible
to use a Form S-3 registration statement at the time of such Block Trade. Such Holders only need to notify the Company of the Block
Trade five Business Days prior to the day such offering is to commence (unless a longer period is agreed to by Holders) and the Company
shall as expeditiously as possible use its commercially reasonable efforts to facilitate such offering (which may close as early as two
(2) Business Days after the date it commences); provided that Holders wishing to engage in the underwritten block trade shall use
commercially reasonable efforts to work with the Company and the underwriters prior to making such request in order to facilitate preparation
of the registration statement, prospectus and other offering documentation related to the underwritten Block Trade. Each Holder agrees
that such Holder shall treat as confidential the receipt of the Shelf Offering notice and shall not disclose or use the information contained
in such Shelf Offering notice without the prior written consent of the Company or until such time as the information contained therein
is or becomes available to the public generally, other than as a result of disclosure by the Holder in breach of the terms of this Agreement.
(ii) If
any of the Registrable Securities covered by the Shelf Registration are to be sold pursuant to an Underwritten Offering, the managing
underwriter or underwriters thereof shall be designated by the Participating Holders, provided that such designated managing underwriter
or underwriters is or are reasonably acceptable to the Company.
(iii) The
Company shall, at the request of Participating Holders covered by a Shelf Registration Statement, file any prospectus supplement or any
post-effective amendments and otherwise take any action necessary to include therein all disclosure and language deemed necessary or
advisable by such Holders to effect such Shelf Offering.
(c) Effectiveness.
(i) The
Company shall use commercially reasonable efforts to have the Shelf Registration Statement or New Registration Statement declared effective
as soon as practicable but in no event later than the Effectiveness Deadline (including filing with the SEC a request for acceleration
of effectiveness in accordance with Rule 461 promulgated under the Securities Act), and shall use its commercially reasonable efforts
to keep the Shelf Registration Statement or New Registration Statement continuously effective under the Securities Act until the earlier
of (A) such time as all of the Registrable Securities covered by such Registration Statement have been publicly sold by the Holders,
or (B) the date that all the Shares cease to be Registrable Securities (the “Effectiveness Period”); provided,
that, the Company will not be obligated to update the Registration Statement and no sales may made under the applicable Registration
Statement during any Allowed Delay (as defined below) of which the Holders have received notice. The Company shall notify the Participating
Holders of the effectiveness of a Registration Statement by e-mail as promptly as practicable, and shall, if requested provide the Participating
Holders with copies of the final Prospectus to be used in connection with the sale or other disposition of the securities covered thereby.
(ii) For
not more than forty-five (45) consecutive days or for a total of not more than ninety (90) days, in each case in any twelve (12) month
period, the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section 2
if (A) the negotiation or consummation of a transaction by the Company is pending or an event has occurred, which negotiation, consummation
or event, the Board reasonably believes, upon the advice of legal counsel, would require additional disclosure by the Company in the
Registration Statement of material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure
of which in the Registration Statement would be expected, in the reasonable determination of the Board, upon the advice of legal counsel,
to cause the Registration Statement to fail to comply with applicable disclosure requirements, or (B) the Company determines in
good faith, upon advice of legal counsel, that such suspension is necessary to amend or supplement the Registration Statement or the
related Prospectus so that such Registration Statement or Prospectus shall not include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein, in the case of the Prospectus in
light of the circumstances under which they were made, not misleading (an “Allowed Delay”); provided, that
the Company shall promptly (1) notify each Participating Holder in writing of the commencement of an Allowed Delay, but shall not
(without the prior written consent of a Participating Holder) disclose to such Participating Holder any material non-public information
giving rise to an Allowed Delay, (2) advise the Participating Holders in writing to cease all sales under such Registration Statement
until the end of the Allowed Delay and (3) use commercially reasonable efforts to terminate an Allowed Delay as promptly as practicable.
(d) In
the event that Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall
(i) register the resale of the Registrable Securities on another appropriate form reasonably acceptable to the Holders and (ii) undertake
to register the Registrable Securities on Form S-3 promptly after such form is available; provided, that the Company shall
maintain the effectiveness of the Registration Statement then in effect until such time as a Registration Statement on Form S-3
covering the Registrable Securities has been declared effective by the SEC.
(e) Liquidated
Damages.
(i) Subject
to Section 2.1(b)(ii), if a Registration Statement covering the Registrable Securities is not filed with the SEC on or prior to
the Filing Deadline, the Company will make pro rata payments to each Holder then holding Registrable Securities, as liquidated damages
and not as a penalty (the “Registration Liquidated Damages”), in an amount equal to one percent (1.0%) of the aggregate
amount invested by such Holder for the initial day of failure to file such Registration Statement by the Filing Deadline and for each
30-day period (or pro rata portion thereof with respect to a final period, if any) thereafter during which no such Registration Statement
is filed with respect to the Registrable Securities, provided that, in no event will the total Registration Liquidated Damages exceed
6% of the gross proceeds received by the Company under the Purchase Agreement. Such payments shall be made to each Holder then holding
Registrable Securities in cash no later than ten (10) Business Days after the end of the date of the initial failure to file such
Registration Statement by the Filing Deadline and each subsequent 30-day period (or portion thereof with respect to a final period, if
any) thereafter until such Registration Statement is filed with respect to the Registrable Securities. Interest shall accrue at the rate
of one percent (1.0%) per month on any such liquidated damages payments that shall not be paid by the applicable payment date until such
amount is paid in full.
(ii) Subject
to Section 2.1(b)(ii), if (1)(A) a Registration Statement covering the Registrable Securities is not declared effective by
the SEC (x) prior to the earlier of five (5) Business Days after the SEC informs the Company that no review of such Registration
Statement will be made or that the SEC has no further comments on such Registration Statement or (y) the Effectiveness Deadline
or (B) after a Registration Statement has been declared effective by the SEC, such Registration Statement ceases for any reason
(including, without limitation, by reason of a stop order, or the Company’s failure to update the Registration Statement) to remain
continuously effective as to sell all Registrable Securities for which it is required to be effective, (2) the Holders are not permitted
to utilize the Prospectus therein to resell such Registrable Securities (other than during an Allowed Delay pursuant to Section 2.1(b)(ii)),
(3) any Allowed Delay pursuant to Section 2.1(b)(ii) exceeds the permitted length set forth therein, or (4) after
the Filing Deadline, and only in the event a Registration Statement is not effective or available to sell all Registrable Securities,
the Company fails to file with the SEC any required reports under Section 13 or 15(d) of the Exchange Act such that it is not
in compliance with Rule 144(c)(1), as a result of which holders who are not affiliates are unable to sell Registrable Securities
without restriction under Rule 144 (each of (1) through (4), a “Maintenance Failure”), then in addition
to any other rights the Purchaser may have hereunder or under applicable law, then the Company will make pro rata payments to each Holder
then holding Registrable Securities, as liquidated damages and not as a penalty (the “Maintenance Liquidated Damages,”
and together with the Registration Liquidated Damages, the “Liquidated Damages”), in an amount equal to one percent
(1.0%) of the aggregate amount invested by such Holder for the Registrable Securities then held by such Holder for each 30-day period
(or pro rata portion thereof with respect to a final period, if any) thereafter until the Maintenance Failure is cured, provided that,
in no event will the total Maintenance Liquidated Damages exceed 6% of the gross proceeds received by the Company under the Purchase
Agreement. The Maintenance Liquidated Damages shall be paid monthly within ten (10) Business Days of the date of such Maintenance
Failure and the end of each subsequent 30-day period (or portion thereof with respect to a final period, if any) thereafter until the
Maintenance Failure is cured. Such payments shall be made to each Holder then holding Registrable Securities in cash. Interest shall
accrue at the rate of one percent (1%) per month on any such liquidated damages payments that shall not be paid by the applicable payment
date until such amount is paid in full.
2.2 Expenses.
The Company will pay all expenses associated with each Registration Statement, including filing and printing fees, the Company’s
counsel and accounting fees and expenses, costs associated with clearing the Registrable Securities for sale under applicable state securities
laws and listing fees, but excluding discounts, commissions, fees of underwriters, selling brokers, dealer managers or similar securities
industry professionals with respect to the Registrable Securities being sold.
2.3 Company
Obligations.In the case of the registration effected by the Company pursuant to this Agreement, the Company shall, upon reasonable request,
inform the Holder as to the status of such registration. The Company will use commercially reasonable efforts to effect the registration
of the Registrable Securities in accordance with the terms hereof and pursuant thereto, the Company will:
(a) prepare
the required Registration Statement including all exhibits and financial statements required under the Securities Act to be filed therewith,
and provide copies to and permit each Participating Holder to review each Registration Statement and all amendments and supplements thereto
prior to their filing with the SEC and a reasonable opportunity to furnish comments thereon (it being acknowledged and agreed that if
a Participating Holder does not object to or comment on the aforementioned documents, then the Participating Holder shall be deemed to
have consented to and approved the use of such documents). The Purchaser and its counsel shall have at least five (5) Business Days
prior to the anticipated filing date of a Registration Statement to review and comment upon such Registration Statement and any amendment
or supplement to such Registration Statement and any related prospectus (including any documents incorporated by reference therein),
prior to its filing with the SEC. The Company shall (a) use its reasonable best efforts to address in each such document prior to
being so filed with the SEC such comments as the Purchaser or its counsel reasonably proposed by the Purchaser, and (b) not file
any Registration Statement or related prospectus or any amendment or supplement thereto containing information regarding the Purchaser
to which the Purchaser reasonably objects, unless such information is required to comply with any applicable law or regulation;
(b) file
with the SEC a Registration Statement relating to the Registrable Securities including all exhibits and financial statements required
by the SEC to be filed therewith, and use commercially reasonable efforts to cause such Registration Statement to become effective under
the Securities Act;
(c) prepare
and file with the SEC such amendments and post-effective amendments to such Registration Statement and the related Prospectus as may
be necessary to keep such Registration Statement effective for the Effectiveness Period and to comply with the provisions of the Securities
Act and the Exchange Act with respect to the distribution of all of the Registrable Securities covered thereby;
(d) (i) notify
the Participating Holders by facsimile or e-mail as promptly as practicable after any Registration Statement is declared effective or
any post-effective amendment to a Registration Statement is declared effective, and shall simultaneously provide the Participating Holders
with copies of any related Prospectus to be used in connection with the sale or other disposition of the securities covered thereby (provided,
that the Company will not have any obligation to provide any document pursuant to this clause that is available on the EDGAR system),
(ii) promptly notify the Participating Holders no later than one (1) trading day following the date (A) of the issuance
by the SEC of any stop order suspending the effectiveness of such Registration Statement covering any or all of the Registrable Securities
or any order by the SEC preventing or suspending the use of any preliminary or final Prospectus or the initiation of any proceedings
for such purposes, (B) of the receipt by the Company of any notification with respect to the suspension of the qualification of
the Registrable Securities for offering or sale in any jurisdiction and (C) of the receipt by the Company of any notification with
respect to the initiation or threatening of any proceeding for the suspension of the qualification of the Registrable Securities for
offering or sale in any jurisdiction;
(e) promptly
notify the Participating Holders, at any time prior to the end of the Effectiveness Period, upon discovery that, or upon the happening
of any event as a result of which, the Prospectus includes an untrue statement of a material fact or omits to state any material fact
required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing
(provided that such notice shall not, without the prior written consent of a Participating Holder, disclose to such Participating
Holder any material nonpublic information regarding the Company), and promptly prepare, file with the SEC and furnish to such Holder
a supplement to or an amendment of such Prospectus as may be necessary so that such Prospectus shall not include an untrue statement
of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading
in light of the circumstances then existing;
(f) promptly
incorporate in a Prospectus supplement, Free Writing Prospectus or post-effective amendment to the applicable Registration Statement
such information as the Participating Holders reasonably request to be included therein relating to the plan of distribution with respect
to such Registrable Securities, and make all required filings of such Prospectus supplement, Free Writing Prospectus or post-effective
amendment as soon as reasonably practicable after being notified of the matters to be incorporated in such Prospectus supplement, Free
Writing Prospectus or post-effective amendment;
(g) furnish
to each Participating Holder whose Registrable Securities are included in any Registration Statement (i) promptly after the same
is prepared and filed with the SEC, if requested by the Participating Holder, one (1) copy of any Registration Statement and any
amendment thereto, each preliminary prospectus and Prospectus and each amendment or supplement thereto, and each letter written by or
on behalf of the Company to the SEC or the staff of the SEC, and each item of correspondence from the SEC or the staff of the SEC, in
each case relating to such Registration Statement (other than any portion thereof which contains information for which the Company has
sought confidential treatment), and (ii) such number of copies of a Prospectus, including a preliminary prospectus, and all amendments
and supplements thereto and such other documents as such Participating Holder may reasonably request in order to facilitate the disposition
of the Registrable Securities owned by such Participating Holder that are covered by such Registration Statement;
(h) on
or prior to the date on which the Registration Statement is declared effective, use its commercially reasonable efforts to register or
qualify, or cooperate with the Participating Holders and their respective counsel, in connection with the registration or qualification
(or exemption from the registration or qualification) of such Registrable Securities for offer and sale under the applicable state securities
or “Blue Sky” laws of those jurisdictions within the United States as any Participating Holder or their respective counsel
reasonably request in writing and do any and all other acts or things reasonably necessary or advisable to keep such registration or
qualification (or exemption therefrom) in effect during the Effectiveness Period, provided that the Company shall not be required
to qualify generally to do business or as a dealer in securities in any jurisdiction where it is not then so qualified or to take any
action which would subject it to taxation or general service of process in any such jurisdiction where it is not then so subject;
(i) within
one (1) Business Days after a Registration Statement which covers Registrable Securities is declared effective by the SEC, the Company
shall deliver to the transfer agent for such Registrable Securities (with copies to the Participating Holder whose Registrable Securities
are included in such Registration Statement) confirmation that such Registration Statement has been declared effective by the SEC;
(j) cooperate
with each Participating Holder participating in the disposition of such Registrable Securities and their respective counsel in connection
with any filings required to be made with FINRA or any other securities regulatory authority;
(k) otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the SEC under the Securities Act and
the Exchange Act, including, without limitation, Rule 172 under the Securities Act, and file any final Prospectus, including any
supplement or amendment thereof, with the SEC pursuant to Rule 424 under the Securities Act, promptly inform the Participating Holders
in writing if, at any time during the Effectiveness Period, the Company does not satisfy the conditions specified in Rule 172 and,
as a result thereof, the Participating Holders are required to deliver a Prospectus in connection with any disposition of Registrable
Securities and take such other actions as may be reasonably necessary to facilitate the registration of the Registrable Securities hereunder;
and make available to its security holders, as soon as reasonably practicable, an earnings statement covering satisfying the provisions
of Section 11(a) of the Securities Act;
(l) provide
and cause to be maintained a transfer agent and registrar for all Registrable Securities covered by the applicable Registration Statement
from and after a date no later than the effective date of such Registration Statement;
(m) use
commercially reasonable efforts to maintain the listing of all Registrable Securities on each securities
exchange on which the Common Stock is then listed or quoted and on each inter-dealer quotation system on which any of the Common Stock
is then quoted;
(n) comply
with its obligations regarding the removal of restrictive legends as set forth in Section 6(d) of the Purchase Agreement;
(o) with
a view to making available to the Purchaser the benefits of Rule 144 (or its successor rule) and any other rule or regulation
of the SEC that may at any time permit the Purchaser to sell shares of Common Stock to the public without registration, for so long as
the Purchaser hold Shares, the Company covenants and agrees to: (i) make and keep public information available, as those terms are
understood and defined in Rule 144, until the earlier of (A) the date as all of the Registrable Securities shall have been
otherwise transferred, new certificates (or book entry issuance, as applicable) for such Shares not bearing a legend restricting further
transfer shall have been delivered by Company and subsequent public distribution of such Shares shall not require registration under
the Securities Act or (B) such date as all of the Registrable Securities shall have been resold; and (ii) file with the SEC
in a timely manner all reports and other documents required of the Company under the Exchange Act.(iii) furnish to the Purchaser
upon request, as long as the Purchaser owns any Registrable Securities, (A) a written statement by the Company that it has complied
with the reporting requirements of the Exchange Act, (B) a copy of the Company’s most recent Annual Report on Form 10-K
or Quarterly Report on Form 10-Q, and (C) such other information as may be reasonably requested in order to avail the Purchaser
of any rule or regulation of the SEC that permits the selling of any such Registrable Securities without registration;
(p) If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common Stock
then registered in a Registration Statement, file as soon as reasonably practicable, but in any case prior to the Filing Deadline, an
additional Registration Statement covering the resale by the Holders of not less than the number of such Registrable Securities;
(q) If
reasonably requested by the Purchaser at any time in respect of any Registration Statement, the Company shall deliver to the Purchaser
a written confirmation from Company’s counsel of whether or not the effectiveness of such Registration Statement has lapsed at
any time for any reason (including, without limitation, the issuance of a stop order) and whether or not such Registration Statement
is currently effective and available to the Company for sale of Registrable Securities;
(r) enter
into and perform such customary agreements (including underwriting agreements in customary form) and take all such other actions as the
Holders or the underwriters, if any, reasonably request in order to expedite or facilitate the disposition of such Registrable Securities
pursuant to a Shelf Offering;
(s) make
available for reasonable inspection by any seller of Registrable Securities, any underwriter participating in any disposition pursuant
to such registration statement and any attorney, accountant or other agent retained by any such seller or underwriter, all material financial
and other records, material pertinent corporate and business documents and properties of the Company as shall be reasonably necessary
to enable them to exercise their due diligence responsibility, and cause the Company’s officers, directors, employees, agents,
representatives and independent accountants to supply all material information reasonably requested by any such seller, underwriter,
attorney, accountant or agent in connection with such registration statement;
(t) in
the case of any underwritten Shelf Offering, use its commercially reasonable efforts to make available by videoconference the executive
officers of the Company to participate with the Holders of Registrable Securities covered by the registration statement and any underwriters
in any virtual “road shows” or other virtual selling efforts that may be reasonably requested by the Holders in connection
with the methods of distribution for the Registrable Securities;
(u) in
the case of any underwritten Shelf Offering, use its commercially reasonable efforts to obtain one or more cold comfort letters from
the Company’s independent public accountants in customary form and covering such matters of the type customarily covered by cold
comfort letters as the underwriters of the Registrable Securities being sold reasonably request;
(v) in
the case of any underwritten Shelf Offering, use its commercially reasonable efforts to provide a legal opinion and negative assurance
letter of the Company’s outside counsel (and to allow the outside counsel to any underwriters to deliver the same), dated the closing
date of the Shelf Offering, in customary form and covering such matters of the type customarily covered by legal opinions of such nature,
which opinion shall be addressed to the underwriters of such Registrable Securities being sold; and
(w) in
connection with any Underwritten Offering, the Company agrees to be bound by the underwriting agreement’s lockup restrictions with
customary exceptions including for issuance of securities of the Company in connection with acquisitions or other strategic transactions
and to cause its executive officers and directors to enter into customary lock-up agreements and shall take commercially reasonable efforts
to cause any other parties reasonably requested by the underwriters to enter into such agreements; provided, however, that in no event
shall such lockup restrictions last more than 45 days.
2.4 Obligations
of the Purchaser.
(a) Notwithstanding
any other provision of the Agreement, no Holder of Registrable Securities may include any of its Registrable Securities in the Registration
Statement pursuant to this Agreement unless the Holder furnishes to the Company a completed and signed selling stockholder questionnaire
in customary form (or such other questionnaire or statement reasonably acceptable to the Company) that contains such information regarding
Purchaser, the securities of the Company held by Purchaser and the intended method of disposition of the Registrable Securities as shall
be reasonably requested by the Company to effect the registration of the Registrable Securities at least five (5) Business Days
prior to the anticipated filing date of any Registration Statement if the Purchaser elects to have any of its Registrable Securities
included in the Registration Statement. Each Holder who intends to include any of its Registrable Securities in the Registration Statement
shall promptly furnish the Company in writing such other information as the Company may reasonably request in writing, and no later than
two (2) Business Days prior to the anticipated filing date of such Registration Statement. Each Holder acknowledges and agrees that
the information in the selling shareholder questionnaire or request for further information as described in this Section 2.4(a) will
be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the
Registration Statement. The Company shall not be obligated to file more than one post-effective amendment or supplement in any thirty
(30) day period following the date such Registration Statement is declared effective for the purposes of naming Holders as selling security
holders who are not named in such Registration Statement at the time of effectiveness.
(b) The
Purchaser, by its acceptance of the Registrable Securities agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of a Registration Statement hereunder, unless the Purchaser has notified the Company in
writing of its election to exclude all of its Registrable Securities from such Registration Statement. The Company may require each selling
Holder to furnish to the Company a statement as to (i) the number of shares of Common Stock beneficially owned by such Holder and
any affiliate thereof, (ii) any FINRA affiliations, (iii) any natural persons who have the power to vote or dispose of the
Common Stock and (iv) any other information as may be requested by the SEC, FINRA or any state securities commission.
(c) The
Purchaser agrees that, upon receipt of any notice from the Company of either (i) the commencement of an Allowed Delay pursuant to
Section 2.1(b) or (ii) the happening of any event of the kind described in Section 2.3(d) and Section 2.3(e) hereof,
the Purchaser will immediately discontinue disposition of Registrable Securities pursuant to the Registration Statement covering such
Registrable Securities, until the Purchaser is advised by the Company that such dispositions may again be made and/or the use of the
applicable Prospectus (as it may have been supplemented or amended) may be resumed and, if so directed by the Company, each Holder will
deliver to the Company or destroy (at the Company’s expense) all copies, other than permanent file copies then in its possession,
of the Prospectus covering such Registrable Securities current at the time of receipt of such notice.
2.5 Indemnification.
(a) Indemnification
by the Company. The Company will indemnify and hold harmless each Participating Holder who sells Registrable Securities covered by such
Registration Statement and its officers, directors, members, employees, advisers and agents, successors and assigns, any underwriter
(as defined in the Securities Act) for each such Participating Holder and each other person, if any, who controls such Participating
Holder or underwriter within the meaning of the Securities Act, against any losses, claims, damages, liabilities and expense (including
reasonable attorney fees) (collectively, “Losses”), actually incurred, joint or several, to which they may become
subject under the Securities Act or otherwise, insofar as such Losses (or actions in respect thereof) arise out of or are based upon:
(i) any untrue statement or alleged untrue statement of any material fact contained in any Registration Statement, any preliminary
Prospectus or final Prospectus, or any amendment or supplement thereof or arising out of or relating to any omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus
or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading; or (ii) any
violation by the Company or its agents of any rule or regulation promulgated under the Securities Act applicable to the Company
or its agents and relating to action or inaction required of the Company in connection with such registration; and will reimburse such
Participating Holder or underwriter who sells Registrable Securities covered by such Registration Statement, and each such officer, director,
employee, agent or member and each such controlling person for any legal or other expenses reasonably incurred by them in connection
with investigating or defending any such Loss or action; provided, however, that the Company will not be liable in any
such case to the extent that any such Losses arise out of or are based upon (x) an untrue statement or alleged untrue statement
or omission or alleged omission so made in reliance upon or in conformity with information furnished by the Purchaser or any such controlling
person in writing specifically for use in such Registration Statement or Prospectus (preliminary, final or summary) or any amendment
or supplement thereto or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution
of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in the Registration Statement, such
Prospectus or such form of Prospectus or in any amendment or supplement thereto, (y) the use by a Holder of an outdated or defective
Prospectus after the Company has notified such Holder in writing that such Prospectus is outdated or defective or (z) a Purchaser’s
(or any other indemnified Person’s) failure to send or give a copy of the Prospectus or supplement (as then amended or supplemented),
if required, pursuant to Rule 172 under the Securities Act (or any successor rule) to the Persons asserting an untrue statement
or alleged untrue statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities
to such Person if such statement or omission was corrected in such Prospectus or supplement.
(b) Indemnification
by the Participating Holders. Each Holder agrees to indemnify and hold harmless, to the fullest extent permitted by law, the Company,
its directors, officers, employees, stockholders, agents, and each person who controls the Company (within the meaning of the Securities
Act and the Exchange Act) against any Losses (i) arising out of, based on, or resulting from any untrue statement of a material
fact or any omission of a material fact required to be stated in any Registration Statement or Prospectus (preliminary, final or summary)
or any amendment or supplement thereto or necessary to make the statements therein (in the case of any Prospectus or form of prospectus
or supplement thereto, in light of the circumstances under which they were made) not misleading, to the extent, but only to the extent
that such untrue statement or omission is contained in any information furnished in writing by such Holder to the Company specifically
for inclusion in such Registration Statement or Prospectus or amendment or supplement thereto, or a document incorporated by reference
into any of the foregoing; or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution
of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or such form of Prospectus or in any amendment or supplement thereto or (ii) related to the use by such Holder of an
outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective.
In no event shall the liability of any selling Holder under this Section 2.5(b) and Section 2.5(d), if applicable, in
the aggregate be greater in amount than the dollar amount of the net proceeds received by such Holder upon the sale of the Registrable
Securities included in the Registration Statement giving rise to such indemnification obligation.
(c) Conduct
of Indemnification Proceedings. Any Person entitled to indemnification hereunder shall (i) give prompt written notice to the indemnifying
party of any claim with respect to which it seeks indemnification and (ii) permit such indemnifying party to assume the defense
of such claim with counsel reasonably satisfactory to the indemnified party (provided, however, that such indemnified party
shall, at the expense of the indemnified party, be entitled to counsel of its own choosing to monitor such defense); provided
that, subject to the preceding sentence, any Person entitled to indemnification hereunder shall have the right to employ separate counsel
and to participate in the defense of such claim, but the fees and expenses of such counsel shall be at the expense of such Person unless
(A) the indemnifying party has agreed to pay such fees or expenses, or (B) the indemnifying party shall have failed to assume
the defense of such claim and employ counsel reasonably satisfactory to such person or (C) in the reasonable judgment of any such
Person, based upon written advice of its counsel, a conflict of interest exists between such person and the indemnifying party with respect
to such claims (in which case, if the Person notifies the indemnifying party in writing that such Person elects to employ separate counsel
at the expense of the indemnifying party, the indemnifying party shall not have the right to assume the defense of such claim on behalf
of such Person); and provided, further, that the failure of any indemnified party to give notice as provided herein shall
not relieve the indemnifying party of its obligations hereunder, except to the extent that such failure to give notice shall materially
adversely affect the indemnifying party in the defense of any such claim or litigation. It is understood that the indemnifying party
shall not, in connection with any proceeding in the same jurisdiction, be liable for fees or expenses of more than one separate firm
of attorneys at any time for all such indemnified parties. No indemnifying party will, except with the consent of the indemnified party,
consent to entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by the
claimant or plaintiff to such indemnified party of a release from all liability in respect of such claim or litigation. The indemnification
provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the indemnified
party, or any officer, director, employee, agent, affiliate, or controlling person of such indemnified party and shall survive the transfer
of the Shares.
(d) Contribution.
If for any reason the indemnification provided for in the preceding paragraphs (a) and (b) is unavailable to an indemnified
party or insufficient to hold it harmless, other than as expressly specified therein, then the indemnifying party shall contribute to
the amount paid or payable by the indemnified party as a result of such loss, claim, damage or liability in such proportion as is appropriate
to reflect the relative fault of the indemnified party and the indemnifying party, as well as any other relevant equitable considerations.
No Person guilty of fraudulent misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled
to contribution from any Person not guilty of such fraudulent misrepresentation. In no event shall the contribution obligation of a Holder
under this Section 2.5(d) and Section 2.5(b), if applicable, in the aggregate be greater in amount than the dollar amount
of the net proceeds received by it upon the sale of the Registrable Securities giving rise to such contribution obligation.
3. Miscellaneous.
3.1 Governing
Law; Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether
of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the
State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The
City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction
contemplated hereby, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum
or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and
consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law.
3.2 Successors
and Assignments. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of
the parties and shall inure to the benefit of each Holder. A Holder may transfer or assign, in whole or from time to time in part, to
one or more persons its rights hereunder in connection with the transfer of Registrable Securities by such Holder to such person, provided
that such Holder complies with all laws applicable thereto, and the provisions of this Agreement and the Purchase Agreement, and
provides written notice of assignment to the Company promptly after such assignment is effected, and such person agrees in writing to
be bound by all of the provisions contained herein. This Agreement may not be assigned by the Company (whether by operation of law or
otherwise) without the prior written consent of the Purchaser, provided, however, that in the event that the Company is
a party to a merger, consolidation, share exchange or similar business combination transaction in which the Common Stock is converted
into the equity securities of another Person, from and after the effective time of such transaction, such Person shall, by
virtue of such transaction, be deemed to have assumed the obligations of the Company hereunder, the term “Company” shall
be deemed to refer to such Person and the term “Registrable Securities” shall be deemed to include the securities received
by the Holders in connection with such transaction unless such securities are otherwise freely tradable by the Holders after giving effect
to such transaction.
3.3 Entire
Agreement; Amendment. This Agreement and the other Transaction Agreements constitute the full and entire understanding and agreement
between the parties with regard to the subjects hereof and thereof. Any previous agreements among the parties relative to the specific
subject matter hereof are superseded by this Agreement. This Agreement may be amended only by a writing signed by the Company and the
Purchaser. The Company may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only
if the Company shall have obtained the written consent to such amendment, action or omission to act of the Purchaser.
3.4 Notices.
All notices and other communications provided for or permitted hereunder shall be made as set forth in Section 8(f) of the
Purchase Agreement.
3.5 Third
Parties. This Agreement does not create any rights, claims or benefits inuring to any person that is not a party hereto nor create
or establish any third party beneficiary hereto; provided, that the indemnified parties are intended third party beneficiaries
of Section 2.5 and each Holder are intended third party beneficiaries of this Agreement.
3.6 Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable efforts
to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed the remaining
terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or
unenforceable.
3.7 Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any
of the provisions hereof.
3.8 Counterparts.
This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement
and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that
the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose
behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were
an original thereof.
3.9 Delays
or Omissions. It is agreed that no delay or omission to exercise any right, power or remedy accruing to any party upon any breach
or default of any other party under this Agreement shall impair any such right, power or remedy, nor shall it be construed to be a waiver
of any such breach or default, or any acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver
of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further
agreed that any waiver, permit, consent or approval of any kind or character of any breach or default under this Agreement, or any waiver
of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set forth
in writing, and that all remedies, either under this Agreement, by law or otherwise, shall be cumulative and not alternative.
3.10 Consents.
Any permission, consent, or approval of any kind or character under this Agreement shall be in writing and shall be effective only to
the extent specifically set forth in such writing.
3.11 SPECIFIC
PERFORMANCE. THE PARTIES HERETO AGREE THAT IRREPARABLE DAMAGE WOULD OCCUR IN THE EVENT THAT ANY OF THE PROVISIONS OF THIS AGREEMENT
WERE NOT PERFORMED IN ACCORDANCE WITH ITS SPECIFIC INTENT OR WERE OTHERWISE BREACHED. IT IS ACCORDINGLY AGREED THAT THE PARTIES SHALL
BE ENTITLED TO AN INJUNCTION OR INJUNCTIONS, WITHOUT BOND, TO PREVENT OR CURE BREACHES OF THE PROVISIONS OF THIS AGREEMENT AND TO ENFORCE
SPECIFICALLY THE TERMS AND PROVISIONS HEREOF, THIS BEING IN ADDITION TO ANY OTHER REMEDY TO WHICH THEY MAY BE ENTITLED BY LAW OR
EQUITY, AND ANY PARTY SUED FOR BREACH OF THIS AGREEMENT EXPRESSLY WAIVES ANY DEFENSE THAT A REMEDY IN DAMAGES WOULD BE ADEQUATE.
3.12 Construction
of Agreement. No provision of this Agreement shall be construed against either party as the drafter thereof.
3.13 Section References.
Unless otherwise stated, any reference contained herein to a Section or subsection refers to the provisions of this Agreement.
3.14 Variations
of Pronouns. All pronouns and all variations thereof shall be deemed to refer to the masculine, feminine, or neuter, singular or
plural, as the context in which they are used may require.
3.15 Contract
Interpretation. This Agreement is the joint product of the Purchaser and the Company and each provision hereof has been subject to
the mutual consultation, negotiation and agreement of such parties and shall not be construed for or against any party hereto.
3.16 Non-Recourse.
Notwithstanding anything that may be expressed or implied in this Agreement, the Company covenants, agrees and acknowledges that no recourse
under this Agreement or any documents or instruments delivered in connection with this Agreement shall be had against any current or
future director, officer, employee, stockholder, general or limited partner or member of the Purchaser or of any of its Affiliates or
assignees, whether by the enforcement of any assessment or by any legal or equitable proceeding, or by virtue of any statute, regulation
or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed
on or otherwise be incurred by any current or future director, officer, employee, stockholder, general or limited partner or member of
the Purchaser or of any of its Affiliates or assignees, as such for any obligation of the Purchaser under this Agreement or any documents
or instruments delivered in connection with this Agreement for any claim based on, in respect of or by reason of such obligations or
their creation.
3.17 Cumulative
Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.
3.18 No
Piggyback on Registrations; Prohibition on Filing Other Registration Statements. Neither the Company nor any of its security
holders (other than the Holders in such capacity pursuant hereto) may include securities of the Company in any Registration Statements
other than the Registrable Securities. The Company shall not file any other registration statements until all Registrable Securities
are registered pursuant to a Registration Statement that is declared effective by the SEC, provided that this Section 3.18 shall
not prohibit the Company from filing amendments to registration statements filed prior to the date of this Agreement so long as no new
securities are registered on any such existing registration statements, nor preparing and filing with the SEC a registration statements
on Form S-8 relating to its equity incentive plans.
[Remainder of Page Intentionally Left
Blank; Signature Pages Follow]
IN WITNESS WHEREOF, the parties have executed
this Agreement or caused their duly authorized officers to execute this Agreement as of the day and year first written above.
COMPANY: | |
| | |
VUZIX CORPORATION | |
| | |
By: | /s/ Paul Travers | |
Name: | Paul Travers | |
Title: | Chief Executive Officer | |
IN WITNESS WHEREOF, the parties have executed
this Agreement or caused their duly authorized officers to execute this Agreement as of the day and year first written above.
PURCHASER: |
|
|
|
|
QUANTA COMPUTER INC. |
|
|
|
By: |
/s/ C. C. Leung |
|
Name: |
C. C. Leung |
|
Title: |
Vice Chairman |
|
Annex A
PLAN OF DISTRIBUTION
The selling stockholders, including their transferees,
pledgees or donees or their respective successors, may, from time to time, sell, transfer or otherwise dispose of any or all of their
shares of common stock or interests in shares of common stock on any stock exchange, market or trading facility on which the shares are
traded or in private transactions. These dispositions may be at fixed prices, at prevailing market prices at the time of sale, at prices
related to the prevailing market price, at varying prices determined at the time of sale, or at negotiated prices.
The selling stockholders may use any one or more
of the following methods when disposing of shares or interests therein:
| · | ordinary
brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
| · | block
trades in which the broker-dealer will attempt to sell the shares as agent, but may position
and resell a portion of the block as principal to facilitate the transaction; |
| · | purchases
by a broker-dealer as principal and resale by the broker-dealer for its account; |
| · | an
exchange distribution in accordance with the rules of the applicable exchange; |
| · | privately
negotiated transactions; |
| · | short
sales effected after the date the registration statement of which this prospectus is a part
is declared effective by the SEC; |
| · | through
the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise; |
| · | broker-dealers
may agree with the selling stockholders to sell a specified number of such shares at a stipulated
price per share; |
| · | a
combination of any such methods of sale; and |
| · | any
other method permitted by applicable law. |
The selling stockholders may, from time to time,
pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance
of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock, from time to time, under
this prospectus, or under an amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities
Act, amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders
under this prospectus. The selling stockholders also may transfer the shares of common stock in other circumstances, in which case the
transferees, pledgees or other successors in interest will be the selling stockholders for purposes of this prospectus.
In connection with the sale of our common stock
or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other financial institutions,
which may in turn engage in short sales of the common stock in the course of hedging the positions they assume. The selling stockholders
may also sell shares of our common stock short and deliver these securities to close out their short positions, or loan or pledge the
common stock to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other transactions
with broker-dealers or other financial institutions or the creation of one or more derivative securities which require the delivery to
such broker-dealer or other financial institution of shares offered by this prospectus, which shares such broker-dealer or other financial
institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).
The aggregate proceeds to the selling stockholders
from the sale of the common stock offered by them will be the purchase price of the common stock less discounts or commissions, if any.
Each of the selling stockholders reserves the right to accept and, together with their agents from time to time, to reject, in whole
or in part, any proposed purchase of common stock to be made directly or through agents. We will not receive any of the proceeds from
this offering.
The selling stockholders also may resell all or
a portion of the shares in open market transactions in reliance upon Rule 144 under the Securities Act, provided that they meet
the criteria and conform to the requirements of that rule, or another available exemption from the registration requirements of the Securities
Act.
The selling stockholders and any underwriters,
broker-dealers or agents that participate in the sale of the common stock or interests therein may be “underwriters” within
the meaning of Section 2(a)(11) of the Securities Act. Any discounts, commissions, concessions or profit they earn on any resale
of the shares may be underwriting discounts and commissions under the Securities Act. Selling stockholders who are “underwriters”
within the meaning of Section 2(a)(11) of the Securities Act will be subject to the prospectus delivery requirements of the Securities
Act.
To the extent required, the shares of our common
stock to be sold, the names of the selling stockholders, the respective purchase prices and public offering prices, the names of any
agents, dealer or underwriter, and any applicable commissions or discounts with respect to a particular offer will be set forth in an
accompanying prospectus supplement or, if appropriate, a post-effective amendment to the registration statement that includes this prospectus.
In order to comply with the securities laws of
some states, if applicable, the common stock may be sold in these jurisdictions only through registered or licensed brokers or dealers.
In addition, in some states the common stock may not be sold unless it has been registered or qualified for sale or an exemption from
registration or qualification requirements is available and is complied with.
We have advised the selling stockholders that
the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of shares in the market and to the activities
of the selling stockholders and their affiliates. In addition, to the extent applicable, we will make copies of this prospectus (as it
may be supplemented or amended from time to time) available to the selling stockholders for the purpose of satisfying the prospectus
delivery requirements of the Securities Act. The selling stockholders may indemnify any broker-dealer that participates in transactions
involving the sale of the shares against certain liabilities, including liabilities arising under the Securities Act.
We have agreed to indemnify the selling stockholders
against liabilities, including liabilities under the Securities Act and state securities laws, relating to the registration of the shares
offered by this prospectus.
We have agreed with the selling stockholders to
use commercially reasonable efforts to cause the registration statement of which this prospectus constitutes a part effective and to
remain continuously effective until the earlier of (1) such time as all of the shares covered by this prospectus have been disposed
of pursuant to and in accordance with such registration statement and (2) the date that all the shares covered by this prospectus
cease to be “Registrable Securities” (as defined in the Registration Rights Agreement).
Exhibit 99.1
Quanta
Computer Enters Into a Strategic Investment in Vuzix in Support of Long-Term Waveguide Design and Supply Partnership
| - | Vuzix to receive a $20 million dollar investment in 3 tranches from Quanta Computer, one of the world's
largest ODMs |
| - | Quanta investment to support the expansion of Vuzix’ leading-edge waveguide production capabilities
and joint development of new AR/AI smart glasses technologies |
ROCHESTER, NY, September
3, 2024 – Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart
glasses and Augmented Reality (AR) technology and products, is pleased to announce Quanta Computer Inc. (TWSE: 2382.TW), (“Quanta”),
a global Fortune 500 company and worldwide leading Original Design Manufacturer (ODM), has entered into a $20 million three-tranche strategic
investment in Vuzix consisting of common and preferred stock of Vuzix.
Quanta’s investment
commitment of $20 million consists of three investment tranches. The first investment tranche will consist of $10 million of Vuzix common
stock. The second and third tranches of the total planned investment are $5 million each, are tied to specific milestones, and will consist
of the purchase of Vuzix Series B Preferred Stock.
“We plan to work
closely with Vuzix to support the AR smart glasses industry and today’s investment in Vuzix represents a strong endorsement of our
partnership," said Frank Chuang, Vice President of Quanta Computer.
"Quanta’s
investment today represents another important step in our partnership, which has steadily deepened since we first disclosed it last November,"
said Paul Travers, President and CEO of Vuzix. "This investment, and the ones to follow, will significantly strengthen our balance
sheet and assure that we can implement whatever steps needed to ramp production of waveguides, as well as the co-development of new smart
glasses and related technologies. We look forward expanding our customer relationship and partnership with such a leading product manufacturer
as Quanta, as well as realizing the significant revenue potential it stands to generate for Vuzix in the upcoming years with both parties’
successes.”
The foregoing description
of Quanta’s investment is qualified in its entirety by reference to the Current Report on Form 8-K, filed with the Securities and
Exchange Commission on August xx, 2024 and the agreements attached as exhibits thereto.
About Quanta Computer
Quanta Computer Inc.
is a Fortune Global 500 Company and a leader in worldwide notebook manufacturing, as well as a leading solution provider in cloud computing.
Quanta provides innovative products with superior technology in information and communications, consumer electronics, cloud computing,
smart home solutions, smart automobile solutions, smart healthcare, and AIoT, etc. Founded in 1988 and listed in TWSE since 1999, Quanta
Computer is headquartered in Taiwan with manufacturing and service locations across Asia, Americas, and Europe, etc. FY2023 consolidated
revenues for Quanta Computer amounted to US$35 billion with a workforce of approximately 62,000 employees
worldwide. For further information, please visit Quanta Computer’s Website at http://www.quantatw.com/
About Vuzix Corporation
Vuzix is a leading designer,
manufacturer and marketer of Smart Glasses and Augmented Reality (AR) technologies and products for the enterprise, medical, defense
and consumer markets. The Company’s products include head-mounted smart personal display and wearable computing devices that offer
users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality, as well OEM
waveguide optical components and display engines. Vuzix holds more than 375 patents and patents pending and numerous IP licenses in the
fields of optics, head-mounted displays, and augmented reality Video Eyewear field. Moviynt, an SAP Certified ERP SaaS logistics solution
provider, is a Vuzix wholly owned subsidiary. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years
2005 to 2024 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI)
with offices in: Rochester, NY; and Kyoto and Tokyo, Japan. For more information, visit the Vuzix website, Twitter and
Facebook pages.
Forward-Looking Statements
Disclaimer
Certain statements contained in this news
release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable
Canadian securities laws. Forward-looking statements contained in this release relate to potential impact of investments, the
completion of tranche the second and third investment tranches, Vuzix Smart Glasses, our business relationship and future business
opportunities with Quanta Computer and their customers and among other things the Company's leadership in the Smart Glasses and AR
display industry. They are generally identified by words such as "believes," "may," "expects,"
"anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking
statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results
could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the
Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian
securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and
developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to
update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this
release, except as required by applicable law.
Vuzix Media and Investor Relations Contact:
Ed McGregor, Director of Investor Relations,
Vuzix Corporation
ed mcgregor@vuzix.com
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com www.vuzix.com
v3.24.2.u1
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 2 such as Street or Suite number
+ References
+ Details
Name: |
dei_EntityAddressAddressLine2 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Grafico Azioni Vuzix (NASDAQ:VUZI)
Storico
Da Nov 2024 a Dic 2024
Grafico Azioni Vuzix (NASDAQ:VUZI)
Storico
Da Dic 2023 a Dic 2024